BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453-1466. [PMID: 11085747 DOI: 10.1084/jem.192.10.1453] [Cited by in Crossref: 517] [Cited by in F6Publishing: 483] [Article Influence: 24.6] [Reference Citation Analysis]
Number Citing Articles
1 Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laâbi Y, Xin X, Schneider P, Tschopp J, Mackay CR, Mackay F. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 2004;172:812-22. [PMID: 14707051 DOI: 10.4049/jimmunol.172.2.812] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 7.3] [Reference Citation Analysis]
2 Sthoeger Z, Sharabi A, Mozes E. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. J Autoimmun 2014;54:60-71. [PMID: 24958634 DOI: 10.1016/j.jaut.2014.06.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
3 Qian Y, Conway KL, Lu X, Seitz HM, Matsushima GK, Clarke SH. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood 2006;108:974-82. [PMID: 16861350 DOI: 10.1182/blood-2005-12-006858] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
4 Irons EE, Lau JTY. Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells. Front Immunol 2018;9:2150. [PMID: 30294329 DOI: 10.3389/fimmu.2018.02150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Nardelli B, Moore PA, Li Y, Hilbert DM. B Lymphocyte Stimulator (BLyS): A Therapeutic Trichotomy for the Treatment of B Lymphocyte Diseases. Leukemia & Lymphoma 2009;43:1367-73. [DOI: 10.1080/10428190290033297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004;20:539-50. [PMID: 15142523 DOI: 10.1016/s1074-7613(04)00108-6] [Cited by in Crossref: 229] [Cited by in F6Publishing: 87] [Article Influence: 13.5] [Reference Citation Analysis]
7 Hwang IY, Boularan C, Harrison K, Kehrl JH. Gαi Signaling Promotes Marginal Zone B Cell Development by Enabling Transitional B Cell ADAM10 Expression. Front Immunol 2018;9:687. [PMID: 29696016 DOI: 10.3389/fimmu.2018.00687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Myles A, Cancro MP. The NIK of time for B cells. Eur J Immunol 2016;46:547-51. [PMID: 26873522 DOI: 10.1002/eji.201646294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clinical Biochemistry 2006;39:1131-7. [DOI: 10.1016/j.clinbiochem.2006.09.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
10 Hobeika E, Dautzenberg M, Levit-Zerdoun E, Pelanda R, Reth M. Conditional Selection of B Cells in Mice With an Inducible B Cell Development. Front Immunol 2018;9:1806. [PMID: 30127788 DOI: 10.3389/fimmu.2018.01806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Granja AG, Tafalla C. Different IgM+ B cell subpopulations residing within the peritoneal cavity of vaccinated rainbow trout are differently regulated by BAFF. Fish Shellfish Immunol 2019;85:9-17. [PMID: 28989090 DOI: 10.1016/j.fsi.2017.10.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
12 Wu CC, Wu FC, Hsu YT, Hsiao YC, Yang YC, Chang CA, Chang CL. Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer. Oncotarget 2017;8:33024-36. [PMID: 28423693 DOI: 10.18632/oncotarget.16032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Thorn M, Lewis RH, Mumbey-Wafula A, Kantrowitz S, Spatz LA. BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cell Immunol 2010;261:9-22. [PMID: 19914608 DOI: 10.1016/j.cellimm.2009.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
14 Tafalla C, González L, Castro R, Granja AG. B Cell-Activating Factor Regulates Different Aspects of B Cell Functionality and Is Produced by a Subset of Splenic B Cells in Teleost Fish. Front Immunol 2017;8:295. [PMID: 28360916 DOI: 10.3389/fimmu.2017.00295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
15 De Re V, Caggiari L, Garziera M, De Zorzi M, Repetto O. Molecular signature in HCV-positive lymphomas. Clin Dev Immunol. 2012;2012:623465. [PMID: 22952554 DOI: 10.1155/2012/623465] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
16 Tussiwand R, Bosco N, Ceredig R, Rolink AG. Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol 2009;39:2317-24. [PMID: 19714572 DOI: 10.1002/eji.200939633] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
17 Moreaux J, Legouffe E, Jourdan E, Quittet P, Rème T, Lugagne C, Moine P, Rossi JF, Klein B, Tarte K. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004;103:3148-57. [PMID: 15070697 DOI: 10.1182/blood-2003-06-1984] [Cited by in Crossref: 362] [Cited by in F6Publishing: 317] [Article Influence: 20.1] [Reference Citation Analysis]
18 Lindvall JM, Blomberg KEM, Berglöf A, Smith CE. Distinct gene expression signature in Btk-defective T1 B-cells. Biochemical and Biophysical Research Communications 2006;346:461-9. [DOI: 10.1016/j.bbrc.2006.05.146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
19 Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP. Homeostatic niche specification among naïve and activated B cells: A growing role for the BLyS family of receptors and ligands. Seminars in Immunology 2005;17:193-9. [DOI: 10.1016/j.smim.2005.02.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
20 Tertilt C, Joh J, Krause A, Chou P, Schneeweiss K, Crystal RG, Worgall S. Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 2009;77:3044-55. [PMID: 19364838 DOI: 10.1128/IAI.00927-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
21 Sun J, Li Y, Yu M, Sun Y, Feng J, Shen B. Analysis of an anti-B lymphocyte stimulator monoclonal antibody B7 and its binding activity to myeloma and lymphoma cell lines. Hybridoma (Larchmt) 2006;25:238-42. [PMID: 16934021 DOI: 10.1089/hyb.2006.25.238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Whittle R, Taylor PC. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. Blood 2011;118:6446-9. [DOI: 10.1182/blood-2011-05-354019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
23 Bende RJ, van Maldegem F, van Noesel CJ. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica 2009;94:1109-23. [PMID: 19608670 DOI: 10.3324/haematol.2009.005983] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
24 Thibault-Espitia A, Foucher Y, Danger R, Migone T, Pallier A, Castagnet S, G-Gueguen C, Devys A, C-Gautier A, Giral M. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant. 2012;12:2754-2762. [PMID: 22883025 DOI: 10.1111/j.1600-6143.2012.04194.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
25 Dosenovic P, Soldemo M, Scholz JL, O'Dell S, Grasset EK, Pelletier N, Karlsson MC, Mascola JR, Wyatt RT, Cancro MP, Karlsson Hedestam GB. BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses. J Immunol 2012;188:6018-26. [PMID: 22561155 DOI: 10.4049/jimmunol.1200466] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
26 Kearney JF. Development and Function of B Cell Subsets. Molecular Biology of B Cells. Elsevier; 2004. pp. 155-60. [DOI: 10.1016/b978-012053641-2/50011-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 2002;3:424-9. [PMID: 12424625 DOI: 10.1038/sj.gene.6363923] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
28 Fabris M, Visentini D, De re V, Picierno A, Maieron R, Cannizzaro R, Villalta D, Curcio F, De vita S, Tonutti E. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scandinavian Journal of Gastroenterology 2009;42:1434-9. [DOI: 10.1080/00365520701452225] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
29 Durand CA, Richer MJ, Brenker K, Graves M, Shanina I, Choi K, Horwitz MS, Puri KD, Gold MR. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice. Autoimmunity 2013;46:62-73. [PMID: 23039284 DOI: 10.3109/08916934.2012.732130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
30 Zouali M, Uy EA. Belimumab Therapy in Systemic Lupus Erythematosus. BioDrugs 2013;27:225-35. [DOI: 10.1007/s40259-013-0031-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum 2006;54:723-32. [PMID: 16508933 DOI: 10.1002/art.21650] [Cited by in Crossref: 187] [Cited by in F6Publishing: 167] [Article Influence: 12.5] [Reference Citation Analysis]
32 Grimaldi CM, Jeganathan V, Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol 2006;176:2703-10. [PMID: 16493025 DOI: 10.4049/jimmunol.176.5.2703] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
33 Cancro MP. B cells and aging: gauging the interplay of generative, selective, and homeostatic events. Immunol Rev 2005;205:48-59. [DOI: 10.1111/j.0105-2896.2005.00272.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
34 Thaunat O, Patey N, Gautreau C, Lechaton S, Fremeaux-bacchi V, Dieu-nosjean M, Cassuto-viguier E, Legendre C, Delahousse M, Lang P, Michel J, Nicoletti A. B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy. Transplantation 2008;85:1648-53. [DOI: 10.1097/tp.0b013e3181735723] [Cited by in Crossref: 108] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
35 Parsons RF, Vivek K, Redfield RR 3rd, Migone TS, Cancro MP, Naji A, Noorchashm H. B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) 2010;24:207-21. [PMID: 20655723 DOI: 10.1016/j.trre.2010.05.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
36 Wang LD, Clark MR. B-cell antigen-receptor signalling in lymphocyte development. Immunology 2003;110:411-20. [PMID: 14632637 DOI: 10.1111/j.1365-2567.2003.01756.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
37 Wang HY, Ma CA, Zhao Y, Fan X, Zhou Q, Edmonds P, Uzel G, Oliveira JB, Orange J, Jain A. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. Proc Natl Acad Sci U S A 2013;110:5127-32. [PMID: 23493554 DOI: 10.1073/pnas.1221211110] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
38 Wang J, Lo JC, Foster A, Yu P, Chen HM, Wang Y, Tamada K, Chen L, Fu Y. The regulation of T cell homeostasis and autoimmunity by T cell–derived LIGHT. J Clin Invest 2001;108:1771-80. [DOI: 10.1172/jci200113827] [Cited by in Crossref: 180] [Article Influence: 9.0] [Reference Citation Analysis]
39 Sathkumara HD, De Silva NR, Handunnetti S, De Silva AD. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor. Int J Immunogenet 2015;42:239-53. [DOI: 10.1111/iji.12217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
40 Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunology Letters 2005;101:123-43. [DOI: 10.1016/j.imlet.2005.05.014] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
41 Pott MC, Frede N, Wanders J, Hammarström L, Glocker EO, Glocker C, Tahami F, Grimbacher B. Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies? BMC Immunol 2017;18:34. [PMID: 28651547 DOI: 10.1186/s12865-017-0217-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Amanna IJ, Dingwall JP, Hayes CE. Enforced bcl-xL Gene Expression Restored Splenic B Lymphocyte Development in BAFF-R Mutant Mice. J Immunol 2003;170:4593-600. [DOI: 10.4049/jimmunol.170.9.4593] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
43 Nakamura A, Takai T. A role of FcgammaRIIB in the development of collagen-induced arthritis. Biomed Pharmacother 2004;58:292-8. [PMID: 15194165 DOI: 10.1016/j.biopha.2004.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
44 Shivakumar L, Ansell S. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies. Clin Lymphoma Myeloma. 2006;7:106-108. [PMID: 17026820 DOI: 10.3816/clm.2006.n.046] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
45 Mustafa A, Holladay SD, Witonsky S, Sponenberg DP, Karpuzoglu E, Gogal RM Jr. A single mid-gestation exposure to TCDD yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice. Toxicology 2011;290:156-68. [PMID: 21925233 DOI: 10.1016/j.tox.2011.08.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
46 Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol 2012;90:293-303. [PMID: 22231653 DOI: 10.1038/icb.2011.111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
47 Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA, Kutok JL, Kearney JF, Otipoby KL, Rajewsky K. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009;139:573-86. [PMID: 19879843 DOI: 10.1016/j.cell.2009.08.041] [Cited by in Crossref: 446] [Cited by in F6Publishing: 429] [Article Influence: 37.2] [Reference Citation Analysis]
48 Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8. [PMID: 15701725 DOI: 10.1182/blood-2004-11-4284] [Cited by in Crossref: 405] [Cited by in F6Publishing: 372] [Article Influence: 25.3] [Reference Citation Analysis]
49 Černý J, Stříž I. Adaptive innate immunity or innate adaptive immunity? Clinical Science 2019;133:1549-65. [DOI: 10.1042/cs20180548] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
50 Hayashi EA, Granato A, Paiva LS, Bertho AL, Bellio M, Nobrega A. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor. J Immunol 2010;184:4662-72. [PMID: 20357250 DOI: 10.4049/jimmunol.0903253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
51 De Silva NS, Silva K, Anderson MM, Bhagat G, Klein U. Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells. J Immunol 2016;196:2591-601. [PMID: 26851215 DOI: 10.4049/jimmunol.1501120] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
52 Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells. Diabetes 2009;58:1568-77. [PMID: 19336675 DOI: 10.2337/db08-1504] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
53 Song Y, Buchwald P. TNF superfamily protein-protein interactions: feasibility of small- molecule modulation. Curr Drug Targets 2015;16:393-408. [PMID: 25706111 DOI: 10.2174/1389450116666150223115628] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
54 Jacobi AM, Zhang J, Mackay M, Aranow C, Diamond B. Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One 2009;4:e5776. [PMID: 19488401 DOI: 10.1371/journal.pone.0005776] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
55 Zhu X, Shi Y, Zhang F, Yao Q, Liu Y, Shan N, Wang D, Peng J, Xu J, Hou M. Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia. Br J Haematol 2014;166:783-91. [DOI: 10.1111/bjh.12958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Miyazaki Y, Niino M, Takahashi E, Suzuki M, Mizuno M, Hisahara S, Fukazawa T, Amino I, Nakano F, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Shimohama S, Terayama Y, Kikuchi S. Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis. Clinical Immunology 2018;187:95-101. [DOI: 10.1016/j.clim.2017.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
57 Stohl W, Cheema GS, Briggs WS, Xu D, Sosnovtseva S, Roschke V, Ferrara DE, Labat K, Sattler FR, Pierangeli SS, Hilbert DM. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients. Clin Immunol 2002;104:115-22. [PMID: 12165272 DOI: 10.1006/clim.2002.5238] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
58 Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Rheumatol. 2017;69:1016-1027. [PMID: 28118533 DOI: 10.1002/art.40049] [Cited by in Crossref: 131] [Cited by in F6Publishing: 108] [Article Influence: 32.8] [Reference Citation Analysis]
59 Cuenca M, Romero X, Sintes J, Terhorst C, Engel P. Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses. J Immunol 2016;196:726-37. [PMID: 26667173 DOI: 10.4049/jimmunol.1501266] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
60 Defrance T, Casamayor-Pallejà M, Krammer PH. The life and death of a B cell. Adv Cancer Res 2002;86:195-225. [PMID: 12374279 DOI: 10.1016/s0065-230x(02)86006-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
61 Treml JF, Hao Y, Stadanlick JE, Cancro MP. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 2009;53:1-16. [PMID: 19034695 DOI: 10.1007/s12013-008-9036-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.0] [Reference Citation Analysis]
62 Harfst E, Andersson J, Grawunder U, Ceredig R, Rolink AG. Homeostatic and functional analysis of mature B cells in λ5-deficient mice. Immunology Letters 2005;101:173-84. [DOI: 10.1016/j.imlet.2005.05.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
63 Youinou P, Pers JO. The late news on baff in autoimmune diseases. Autoimmun Rev 2010;9:804-6. [PMID: 20656068 DOI: 10.1016/j.autrev.2010.06.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
64 Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005;42:763-72. [PMID: 15829264 DOI: 10.1016/j.molimm.2004.06.041] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 6.4] [Reference Citation Analysis]
65 Wang SH, Baker JR. Targeting B Cells in Graves’ Disease. Endocrinology 2006;147:4559-60. [DOI: 10.1210/en.2006-0852] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
66 Henley T, Kovesdi D, Turner M. B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta. Eur J Immunol 2008;38:3543-8. [PMID: 19016531 DOI: 10.1002/eji.200838618] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
67 Clatworthy MR, Smith KG. B cells in glomerulonephritis: focus on lupus nephritis. Semin Immunopathol 2007;29:337-53. [PMID: 17943287 DOI: 10.1007/s00281-007-0092-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bertocci B, Lecoeuche D, Sterlin D, Kühn J, Gaillard B, De Smet A, Lembo F, Bole-Feysot C, Cagnard N, Fadeev T, Dahan A, Weill JC, Reynaud CA. Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation. J Immunol 2017;199:2408-20. [PMID: 28807996 DOI: 10.4049/jimmunol.1700708] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
69 Vugmeyster Y, Seshasayee D, Chang W, Storn A, Howell K, Sa S, Nelson T, Martin F, Grewal I, Gilkerson E. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am J Pathol. 2006;168:476-489. [PMID: 16436662 DOI: 10.2353/ajpath.2006.050600] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
70 Einecke G, Reeve J, Mengel M, Sis B, Bunnag S, Mueller TF, Halloran PF. Expression of B Cell and Immunoglobulin Transcripts Is a Feature of Inflammation in Late Allografts: B Cells in Allograft Rejection. American Journal of Transplantation 2008;8:1434-43. [DOI: 10.1111/j.1600-6143.2008.02232.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
71 Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol 2002;168:2101-10. [PMID: 11859095 DOI: 10.4049/jimmunol.168.5.2101] [Cited by in Crossref: 177] [Cited by in F6Publishing: 168] [Article Influence: 9.3] [Reference Citation Analysis]
72 Suryani S, Tangye SG. Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Review of Clinical Immunology 2014;6:765-75. [DOI: 10.1586/eci.10.55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
73 Holl TM, Haynes BF, Kelsoe G. Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods 2010;354:53-67. [PMID: 20109461 DOI: 10.1016/j.jim.2010.01.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
74 Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME. The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 2015;48:301-15. [PMID: 25682089 DOI: 10.1007/s12016-015-8471-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
75 Chang NH, Cheung YH, Loh C, Pau E, Roy V, Cai YC, Wither J. B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One 2010;5:e11691. [PMID: 20661465 DOI: 10.1371/journal.pone.0011691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
76 Jacque E, Schweighoffer E, Tybulewicz VL, Ley SC. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival. J Exp Med 2015;212:883-92. [PMID: 25987726 DOI: 10.1084/jem.20142127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
77 Klocperk A, Mejstříková E, Kayserová J, Kalina T, Šedivá A. Low marginal zone-like B lymphocytes and natural antibodies characterize skewed B-lymphocyte subpopulations in del22q11 DiGeorge patients. Clinical Immunology 2015;161:144-9. [DOI: 10.1016/j.clim.2015.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Geisberger R, Lamers M, Achatz G. The riddle of the dual expression of IgM and IgD. Immunology 2006;118:429-37. [PMID: 16895553 DOI: 10.1111/j.1365-2567.2006.02386.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
79 Gohlke PR, Williams JC, Vilen BJ, Dillon SR, Tisch R, Matsushima GK. The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF. Autoimmunity 2009;42:183-97. [PMID: 19301199 DOI: 10.1080/08916930802668586] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
80 Rahman ZS, Manser T. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J Immunol 2004;173:6179-88. [PMID: 15528355 DOI: 10.4049/jimmunol.173.10.6179] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
81 Zhou HJ, Pham LV, Tamayo AT, Lin-Lee YC, Fu L, Yoshimura LC, Ford RJ. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. Blood 2007;110:2121-7. [PMID: 17567982 DOI: 10.1182/blood-2007-02-073080] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
82 Raymond WD, Eilertsen GØ, Nossent J. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus. Cytokine 2019;114:67-73. [PMID: 30551949 DOI: 10.1016/j.cyto.2018.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
83 Hayashi EA, Akira S, Nobrega A. Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2. J Immunol 2005;174:6639-47. [PMID: 15905502 DOI: 10.4049/jimmunol.174.11.6639] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
84 Brink R. Regulation of B cell self-tolerance by BAFF. Semin Immunol 2006;18:276-83. [PMID: 16916609 DOI: 10.1016/j.smim.2006.04.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
85 Jayasekera JP, Vinuesa CG, Karupiah G, King NJC. Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice. Journal of General Virology 2006;87:3361-71. [DOI: 10.1099/vir.0.82131-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
86 Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol 2009;183:6207-16. [PMID: 19841185 DOI: 10.4049/jimmunol.0803219] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 8.3] [Reference Citation Analysis]
87 Tang X, Tong X, An Y. BAFF gene silencing attenuates allergic airway inflammation by promoting the generation of Tregs via activating pro-Treg cytokines. Life Sci 2020;241:117172. [PMID: 31843529 DOI: 10.1016/j.lfs.2019.117172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
88 Guo F, Weih D, Meier E, Weih F. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. Blood 2007;110:2381-9. [PMID: 17620454 DOI: 10.1182/blood-2007-02-075143] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
89 Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 2016;30:163-72. [PMID: 26139429 DOI: 10.1038/leu.2015.174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
90 Benitez A, Weldon AJ, Tatosyan L, Velkuru V, Lee S, Milford TA, Francis OL, Hsu S, Nazeri K, Casiano CM, Schneider R, Gonzalez J, Su RJ, Baez I, Colburn K, Moldovan I, Payne KJ. Differences in mouse and human nonmemory B cell pools. J Immunol 2014;192:4610-9. [PMID: 24719464 DOI: 10.4049/jimmunol.1300692] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
91 Ramanujam M, Wang X, Huang W, Schiffer L, Grimaldi C, Akkerman A, Diamond B, Madaio MP, Davidson A. Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus. J Immunol 2004;173:3524-34. [DOI: 10.4049/jimmunol.173.5.3524] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
92 Cheng S, Wang H, Zhou H. The Role of TLR4 on B Cell Activation and Anti-β2GPI Antibody Production in the Antiphospholipid Syndrome. J Immunol Res 2016;2016:1719720. [PMID: 27868072 DOI: 10.1155/2016/1719720] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
93 Lawrie S, Bar-or A. B cells set trends: Lessons from multiple sclerosis. Clin Exp Neuroimmunol 2012;3:89-108. [DOI: 10.1111/j.1759-1961.2012.00029.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Zubler RH. Naive and memory B cells in T-cell-dependent and T-independent responses. Springer Semin Immunopathol 2001;23:405-19. [PMID: 11826617 DOI: 10.1007/s281-001-8167-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
95 Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA. 2004;101:3903-3908. [PMID: 14988498 DOI: 10.1073/pnas.0307348101] [Cited by in Crossref: 321] [Cited by in F6Publishing: 292] [Article Influence: 18.9] [Reference Citation Analysis]
96 Lemancewicz D, Bolkun L, Jablonska E, Kulczynska A, Bolkun-skornicka U, Kloczko J, Dzieciol J. Evaluation of TNF superfamily molecules in multiple myeloma patients: Correlation with biological and clinical features. Leukemia Research 2013;37:1089-93. [DOI: 10.1016/j.leukres.2013.05.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
97 Peter HH, Warnatz K. Molecules involved in T-B co-stimulation and B cell homeostasis: possible targets for an immunological intervention in autoimmunity. Expert Opin Biol Ther 2005;5 Suppl 1:S61-71. [PMID: 16187941 DOI: 10.1517/14712598.5.1.s61] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
98 Schuetz C, Niehues T, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev 2010;9:477-82. [PMID: 20146941 DOI: 10.1016/j.autrev.2010.02.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
99 Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, Mcmillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH. TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease. Immunity 2001;15:289-302. [DOI: 10.1016/s1074-7613(01)00183-2] [Cited by in Crossref: 466] [Cited by in F6Publishing: 170] [Article Influence: 23.3] [Reference Citation Analysis]
100 Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 2010;9:604-8. [PMID: 20457281 DOI: 10.1016/j.autrev.2010.05.006] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
101 Fairfax KA, Tsantikos E, Figgett WA, Vincent FB, Quah PS, Lepage M, Hibbs ML, Mackay F. BAFF-driven autoimmunity requires CD19 expression. Journal of Autoimmunity 2015;62:1-10. [DOI: 10.1016/j.jaut.2015.06.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
102 Strömbeck A, Nordström I, Andersson K, Andersson H, Johansen S, Maglio C, Rabe H, Adlerberth I, Wold AE, Hesselmar B, Rudin A, Lundell AC. Allergic disease in 8-year-old children is preceded by delayed B cell maturation. Clin Exp Allergy 2017;47:918-28. [PMID: 28295779 DOI: 10.1111/cea.12922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
103 Yang SH, Gao CY, Li L, Chang C, Leung PSC, Gershwin ME, Lian ZX. The molecular basis of immune regulation in autoimmunity. Clin Sci (Lond) 2018;132:43-67. [PMID: 29305419 DOI: 10.1042/CS20171154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
104 Vaux DL. The buzz about BAFF. J Clin Invest. 2002;109:17-18. [PMID: 11781346 DOI: 10.1172/JCI14780] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
105 Viau M, Zouali M. B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 2005;114:17-26. [PMID: 15596405 DOI: 10.1016/j.clim.2004.08.019] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 6.5] [Reference Citation Analysis]
106 Hentges KE, Yarlagadda SP, Justice MJ. Tnfrsf13c (Baffr) is Mis-expressed in Tumors with Murine Leukemia Virus Insertions at Lvis22. Genomics 2002;80:204-12. [DOI: 10.1006/geno.2002.6812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
107 Feng B, Cheng S, Pear WS, Liou HC. NF-kB inhibitor blocks B cell development at two checkpoints. Med Immunol 2004;3:1. [PMID: 15050028 DOI: 10.1186/1476-9433-3-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
108 Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, Kimberly R, Zhou T. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum 2005;52:3943-54. [PMID: 16320342 DOI: 10.1002/art.21489] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
109 Mackay F, Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine & Growth Factor Reviews 2003;14:311-24. [DOI: 10.1016/s1359-6101(03)00023-6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
110 Pascual V, Banchereau J, Palucka AK. The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol 2003;15:548-56. [PMID: 12960479 DOI: 10.1097/00002281-200309000-00005] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 7.3] [Reference Citation Analysis]
111 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
112 Parsons RF, Vivek K, Redfield RR, Migone TS, Cancro MP, Naji A, Noorchashm H. B-cell tolerance in transplantation: is repertoire remodeling the answer? Expert Rev Clin Immunol 2009;5:703. [PMID: 20161663 DOI: 10.1586/eci.09.63] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
113 Zeng Q, Qin S, Zhang H, Liu B, Qin J, Wang X, Zhang R, Liu C, Dong X, Zhang S, Huang S, Chen L. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. J Cell Physiol 2018;233:516-29. [PMID: 28300280 DOI: 10.1002/jcp.25913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
114 Amezcua Vesely MC, Bermejo DA, Montes CL, Acosta-Rodríguez EV, Gruppi A. B-Cell Response during Protozoan Parasite Infections. J Parasitol Res 2012;2012:362131. [PMID: 22315659 DOI: 10.1155/2012/362131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
115 Lundell AC, Hesselmar B, Nordström I, Adlerberth I, Wold AE, Rudin A. Higher B-cell activating factor levels at birth are positively associated with maternal dairy farm exposure and negatively related to allergy development. J Allergy Clin Immunol 2015;136:1074-1082.e3. [PMID: 25936566 DOI: 10.1016/j.jaci.2015.03.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
116 Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol. 2009;9:767-777. [PMID: 19855403 DOI: 10.1038/nri2656] [Cited by in Crossref: 318] [Cited by in F6Publishing: 297] [Article Influence: 26.5] [Reference Citation Analysis]
117 Burbano C, Villar-Vesga J, Vásquez G, Muñoz-Vahos C, Rojas M, Castaño D. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases. Front Immunol 2019;10:2058. [PMID: 31555283 DOI: 10.3389/fimmu.2019.02058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
118 Lin Z, Dan-Rong Y, Xiao-Qing T, Hao W, Hong-Lian G, Xian-Tao K, Ren-Qian Z, Jiyu L. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients. J Clin Lab Anal 2007;21:183-7. [PMID: 17506477 DOI: 10.1002/jcla.20161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
119 Min YN, Wang CY, Li XX, Hou Y, Qiu JH, Ma J, Shao LL, Zhang X, Wang YW, Peng J. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia. J Thromb Haemost. 2016;14:559-571. [PMID: 26749059 DOI: 10.1111/jth.13246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
120 Morais SA, Vilas-Boas A, Isenberg DA. B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis 2015;7:122-51. [PMID: 26288664 DOI: 10.1177/1759720X15586782] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
121 Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, Hyland L. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J Immunol 2002;169:6193-201. [PMID: 12444124 DOI: 10.4049/jimmunol.169.11.6193] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
122 Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004;197:179-91. [PMID: 14962195 DOI: 10.1111/j.0105-2896.2004.0109.x] [Cited by in Crossref: 325] [Cited by in F6Publishing: 302] [Article Influence: 19.1] [Reference Citation Analysis]
123 Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2020;24:1135-45. [PMID: 32900236 DOI: 10.1080/14728222.2020.1821647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
124 Kimberley FC, Medema JP, Hahne M. APRIL in B-cell Malignancies and Autoimmunity. In: Kalthoff H, editor. Death Receptors and Cognate Ligands in Cancer. Berlin: Springer Berlin Heidelberg; 2009. pp. 161-82. [DOI: 10.1007/400_2008_19] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
125 Peckl-Schmid D, Wolkerstorfer S, Königsberger S, Achatz-Straussberger G, Feichtner S, Schwaiger E, Zaborsky N, Huemer M, Gratz IK, Schibli R, Lamers M, Crameri R, Moser K, Luger EO, Achatz G. HAX1 deficiency: impact on lymphopoiesis and B-cell development. Eur J Immunol 2010;40:3161-72. [PMID: 20865787 DOI: 10.1002/eji.200940221] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
126 Schaller M, Stohl W, Tan SM, Benoit VM, Hilbert DM, Ditzel HJ. Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis 2005;64:743-9. [PMID: 15458959 DOI: 10.1136/ard.2004.025502] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
127 Hobeika E, Nielsen PJ, Medgyesi D. Signaling mechanisms regulating B-lymphocyte activation and tolerance. J Mol Med (Berl). 2015;93:143-158. [PMID: 25627575 DOI: 10.1007/s00109-015-1252-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
128 De Vita S, Quartuccio L, Fabris M. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev 2008;8:95-9. [PMID: 18589005 DOI: 10.1016/j.autrev.2008.05.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
129 Cancro MP. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol Rev 2004;202:237-49. [PMID: 15546397 DOI: 10.1111/j.0105-2896.2004.00212.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
130 Domeier PP, Schell SL, Rahman ZS. Spontaneous germinal centers and autoimmunity. Autoimmunity 2017;50:4-18. [PMID: 28166685 DOI: 10.1080/08916934.2017.1280671] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
131 Yoshida T, Mei H, Dörner T, Hiepe F, Radbruch A, Fillatreau S, Hoyer BF. Memory B and memory plasma cells. Immunol Rev. 2010;237:117-139. [PMID: 20727033 DOI: 10.1111/j.1600-065x.2010.00938.x] [Cited by in Crossref: 189] [Cited by in F6Publishing: 97] [Article Influence: 17.2] [Reference Citation Analysis]
132 Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001;13:195-201. [PMID: 11228413 DOI: 10.1016/s0952-7915(00)00204-1] [Cited by in Crossref: 285] [Cited by in F6Publishing: 108] [Article Influence: 14.3] [Reference Citation Analysis]
133 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest 2002;109:1587-98. [PMID: 12070306 DOI: 10.1172/JCI15034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 72] [Article Influence: 0.3] [Reference Citation Analysis]
134 Maia S, Pelletier M, Ding J, Hsu YM, Sallan SE, Rao SP, Nadler LM, Cardoso AA. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival. PLoS One. 2011;6:e20787. [PMID: 21687682 DOI: 10.1371/journal.pone.0020787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
135 Stohl W, Jacob N, Quinn WJ 3rd, Cancro MP, Gao H, Putterman C, Gao X, Pricop L, Koss MN. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol 2008;181:833-41. [PMID: 18566449 DOI: 10.4049/jimmunol.181.1.833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
136 Figgett WA, Vincent FB, Saulep-Easton D, Mackay F. Roles of ligands from the TNF superfamily in B cell development, function, and regulation. Semin Immunol 2014;26:191-202. [PMID: 24996229 DOI: 10.1016/j.smim.2014.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
137 Rahman ZS, Rao SP, Kalled SL, Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med. 2003;198:1157-1169. [PMID: 14557413 DOI: 10.1084/jem.20030495] [Cited by in Crossref: 172] [Cited by in F6Publishing: 164] [Article Influence: 9.6] [Reference Citation Analysis]
138 Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R. Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches. Immunity 2004;20:785-98. [DOI: 10.1016/j.immuni.2004.05.010] [Cited by in Crossref: 517] [Cited by in F6Publishing: 482] [Article Influence: 30.4] [Reference Citation Analysis]
139 Cui XW, Li JF, Xiao W, Xuan Y, Tian AY, Xu XZ, Zhang SQ. Molecular cloning, expression and functional analysis of TNF13b (BAFF) in Japanese sea perch, Lateolabrax japonicus. Int Immunopharmacol 2012;12:34-41. [PMID: 22032840 DOI: 10.1016/j.intimp.2011.10.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
140 Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene. 2006;25:6758-6780. [PMID: 17072327 DOI: 10.1038/sj.onc.1209943] [Cited by in Crossref: 769] [Cited by in F6Publishing: 725] [Article Influence: 51.3] [Reference Citation Analysis]
141 Aradottir Pind AA, Molina Estupiñan JL, Magnusdottir GJ, Del Giudice G, Jonsdottir I, Bjarnarson SP. LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice That Translates Into Long-Lived Humoral Immunity. Front Immunol 2020;11:527310. [PMID: 33193301 DOI: 10.3389/fimmu.2020.527310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Eibel H, Salzer U, Warnatz K. Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond. Current Opinion in Allergy & Clinical Immunology 2010;10:526-33. [DOI: 10.1097/aci.0b013e32833fea1c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
143 Reddy V, Dahal LN, Cragg MS, Leandro M. Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer? Drug Discov Today. 2016;21:1330-1338. [PMID: 27343722 DOI: 10.1016/j.drudis.2016.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
144 Floch P, Laur AM, Korolik V, Chrisment D, Cappellen D, Idrissi Y, Dubus P, Mégraud F, Lehours P. Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model. Oncotarget 2015;6:34525-36. [PMID: 26439692 DOI: 10.18632/oncotarget.5948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
145 Wang J, Lo JC, Foster A, Yu P, Chen HM, Wang Y, Tamada K, Chen L, Fu YX. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest. 2001;108:1771-1780. [PMID: 11748260 DOI: 10.1172/jci13827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 81] [Article Influence: 0.3] [Reference Citation Analysis]
146 Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med. 2005;202:1527-1538. [PMID: 16330815 DOI: 10.1084/jem.20051971] [Cited by in Crossref: 130] [Cited by in F6Publishing: 117] [Article Influence: 8.7] [Reference Citation Analysis]
147 Castro I, Wright JA, Damdinsuren B, Hoek KL, Carlesso G, Shinners NP, Gerstein RM, Woodland RT, Sen R, Khan WN. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol 2009;182:7729-37. [PMID: 19494297 DOI: 10.4049/jimmunol.0803281] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
148 Groom J, Mackay F. B cells flying solo. Immunol Cell Biol 2008;86:40-6. [PMID: 18172443 DOI: 10.1038/sj.icb.7100142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
149 Vora KA, Wang LC, Rao SP, Liu Z, Majeau GR, Cutler AH, Hochman PS, Scott ML, Kalled SL. Cutting Edge: Germinal Centers Formed in the Absence of B Cell-Activating Factor Belonging to the TNF Family Exhibit Impaired Maturation and Function. J Immunol 2014;171:547-51. [DOI: 10.4049/jimmunol.171.2.547] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 6.2] [Reference Citation Analysis]
150 Tabrizi SJ, Niiro H, Masui M, Yoshimoto G, Iino T, Kikushige Y, Wakasaki T, Baba E, Shimoda S, Miyamoto T, Hara T, Akashi K. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol 2009;182:1490-9. [PMID: 19155496 DOI: 10.4049/jimmunol.182.3.1490] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
151 Thomas M, Calamito M, Srivastava B, Maillard I, Pear WS, Allman D. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood 2007;109:3342-50. [PMID: 17179224 DOI: 10.1182/blood-2006-09-046698] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
152 Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor: BAFF and BCR-mediated B-cell survival. Immunological Reviews 2010;237:205-25. [DOI: 10.1111/j.1600-065x.2010.00944.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 82] [Article Influence: 11.5] [Reference Citation Analysis]
153 Wang X, Meng D. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes. Protein Cell 2015;6:170-84. [PMID: 25503634 DOI: 10.1007/s13238-014-0125-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
154 Tischner D, Woess C, Ottina E, Villunger A. Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis. 2010;1:e48. [PMID: 21364654 DOI: 10.1038/cddis.2010.27] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
155 De S, Barnes BJ. B cell transcription factors: Potential new therapeutic targets for SLE. Clinical Immunology 2014;152:140-51. [DOI: 10.1016/j.clim.2014.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
156 Scholz JL, Oropallo MA, Sindhava V, Goenka R, Cancro MP. The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus. Lupus 2013;22:350-60. [PMID: 23553778 DOI: 10.1177/0961203312469453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
157 Bjersing JL, Tarkowski A, Lundin S, Collins LV. Synergistic action of immunostimulatory DNA and fcgamma receptor IIB-crosslinking on B-cell phenotype and function. Immunobiology 2005;210:23-32. [PMID: 16076031 DOI: 10.1016/j.imbio.2005.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
158 Huang X, Di Liberto M, Cunningham AF, Kang L, Cheng S, Ely S, Liou HC, Maclennan IC, Chen-Kiang S. Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1. Proc Natl Acad Sci USA. 2004;101:17789-17794. [PMID: 15591344 DOI: 10.1073/pnas.0406111101] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
159 Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004;197:192-205. [PMID: 14962196 DOI: 10.1111/j.0105-2896.2004.0112.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 155] [Article Influence: 10.1] [Reference Citation Analysis]
160 Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Swee LK, Rolink A, Izui S. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J Autoimmun 2010;34:349-55. [PMID: 20149596 DOI: 10.1016/j.jaut.2010.01.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
161 Ng LG, Ng CH, Woehl B, Sutherland AP, Huo J, Xu S, Mackay F, Lam KP. BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol 2006;36:1837-46. [PMID: 16791880 DOI: 10.1002/eji.200635956] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
162 Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK. Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. Arthritis Rheum 2007;56:3995-4004. [PMID: 18050196 DOI: 10.1002/art.23062] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
163 Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST. Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009;182:793-801. [PMID: 19124722 DOI: 10.4049/jimmunol.182.2.793] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
164 Xu S, Lam KP. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 2001;21:4067-74. [PMID: 11359913 DOI: 10.1128/MCB.21.12.4067-4074.2001] [Cited by in Crossref: 184] [Cited by in F6Publishing: 68] [Article Influence: 9.2] [Reference Citation Analysis]
165 Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 2009;60:1743-52. [PMID: 19479826 DOI: 10.1002/art.24500] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
166 Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant 2013;22:2279-90. [PMID: 23127285 DOI: 10.3727/096368912X658692] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
167 Tolba KA, Bowers WJ, Eling DJ, Casey AE, Kipps TJ, Federoff HJ, Rosenblatt JD. HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia. Mol Ther 2002;6:455-63. [PMID: 12377186 DOI: 10.1006/mthe.2002.0693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
168 Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-88. [PMID: 14504101 DOI: 10.1182/blood-2003-02-0540] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 12.4] [Reference Citation Analysis]
169 Grimaldi CM, Hicks R, Diamond B. B Cell Selection and Susceptibility to Autoimmunity. J Immunol 2005;174:1775-81. [DOI: 10.4049/jimmunol.174.4.1775] [Cited by in Crossref: 99] [Cited by in F6Publishing: 80] [Article Influence: 6.2] [Reference Citation Analysis]
170 Jacob CO, Pricop L, Putterman C, Koss MN, Liu Y, Kollaros M, Bixler SA, Ambrose CM, Scott ML, Stohl W. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 2006;177:2671-80. [PMID: 16888029 DOI: 10.4049/jimmunol.177.4.2671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
171 Sun L, Zhou L, Chen M, Zhong R, Liu J. Amelioration of systemic lupus erythematosus by Withangulatin A in MRL/lpr mice. J Cell Biochem 2011;112:2376-82. [PMID: 21520246 DOI: 10.1002/jcb.23160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
172 Crestani B, Schneider S, Adle-biassette H, Debray M, Bonay M, Aubier M. Manifestations respiratoires au cours du syndrome de Gougerot-Sjögren. Revue des Maladies Respiratoires 2007;24:535-51. [DOI: 10.1016/s0761-8425(07)91575-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
173 Tedder TF, Poe JC, Haas KM. CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction. Elsevier; 2005. pp. 1-50. [DOI: 10.1016/s0065-2776(05)88001-0] [Cited by in Crossref: 129] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
174 Lindh E, Lind SM, Lindmark E, Hässler S, Perheentupa J, Peltonen L, Winqvist O, Karlsson MC. AIRE regulates T-cell-independent B-cell responses through BAFF. Proc Natl Acad Sci U S A 2008;105:18466-71. [PMID: 19011083 DOI: 10.1073/pnas.0808205105] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
175 Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131:959-971. [PMID: 23465663 DOI: 10.1016/j.jaci.2013.01.046] [Cited by in Crossref: 214] [Cited by in F6Publishing: 176] [Article Influence: 26.8] [Reference Citation Analysis]
176 Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther 2015;17:215. [PMID: 26290435 DOI: 10.1186/s13075-015-0741-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
177 Rose WA 2nd, Okragly AJ, Hu NN, Daniels MR, Martin AP, Koh YT, Kikly K, Benschop RJ. Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production. Front Immunol 2018;9:2871. [PMID: 30574145 DOI: 10.3389/fimmu.2018.02871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
178 Wada K, Maeda K, Tajima K, Kato T, Kobata T, Yamakawa M. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 2009;54:221-32. [DOI: 10.1111/j.1365-2559.2008.03203.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
179 Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome. Scand J Immunol 2005;62:421-8. [PMID: 16305638 DOI: 10.1111/j.1365-3083.2005.01688.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
180 Rathmell JC. B-cell homeostasis: digital survival or analog growth? Immunol Rev 2004;197:116-28. [DOI: 10.1111/j.0105-2896.2004.0096.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
181 Matsushita T, Fujimoto M, Hasegawa M, Matsushita Y, Komura K, Ogawa F, Watanabe R, Takehara K, Sato S. BAFF Antagonist Attenuates the Development of Skin Fibrosis in Tight-Skin Mice. Journal of Investigative Dermatology 2007;127:2772-80. [DOI: 10.1038/sj.jid.5700919] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
182 Genovese MC, Kinnman N, de La Bourdonnaye G, Pena Rossi C, Tak PP. Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial. Arthritis Rheum 2011;63:1793-803. [PMID: 21452293 DOI: 10.1002/art.30373] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
183 Melchers F. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann Rheum Dis 2003;62 Suppl 2:ii25-7. [PMID: 14532143 DOI: 10.1136/ard.62.suppl_2.ii25] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
184 Cancro MP. Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol 2009;9:657-61. [PMID: 19704418 DOI: 10.1038/nri2621] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
185 Szodoray P, Jellestad S, Ohlsson Teague M, Jonsson R. Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome. Lab Invest 2003;83:357-65. [DOI: 10.1097/01.lab.0000059930.92336.e2] [Cited by in Crossref: 48] [Article Influence: 2.7] [Reference Citation Analysis]
186 Moreaux J, Hose D, Jourdan M, Reme T, Hundemer M, Moos M, Robert N, Moine P, De Vos J, Goldschmidt H, Klein B. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines. Haematologica 2007;92:803-11. [PMID: 17550853 DOI: 10.3324/haematol.10574] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
187 Binard A, Le Pottier L, Saraux A, Devauchelle-Pensec V, Pers JO, Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus? J Autoimmun 2008;30:63-7. [PMID: 18155417 DOI: 10.1016/j.jaut.2007.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
188 Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004;63:1096-103. [PMID: 15308519 DOI: 10.1136/ard.2003.018663] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
189 Klomjit N, Fervenza FC, Zand L. Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases. Am J Kidney Dis 2020;76:883-8. [PMID: 32311405 DOI: 10.1053/j.ajkd.2020.02.444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
190 Cai X, Wang M, Kong H, Liu J, Liu Y, Xia W, Zou M, Wang J, Su H, Xu D. Prokaryotic expression, purification and functional characterization of recombinant human RIP2. Mol Biol Rep 2013;40:59-65. [DOI: 10.1007/s11033-012-1995-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
191 Teitell MA, Pandolfi PP. Lymphoid Malignancies. In: Holland EC, editor. Mouse Models of Human Cancer. Hoboken: John Wiley & Sons, Inc.; 2004. [DOI: 10.1002/0471675067.mmc014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
192 Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007;178:7531-9. [PMID: 17548587 DOI: 10.4049/jimmunol.178.12.7531] [Cited by in Crossref: 124] [Cited by in F6Publishing: 108] [Article Influence: 8.9] [Reference Citation Analysis]
193 Sang M, Li J, Wei Z, Wu X, Wang Z, Ma L, Liu H, Zhang S, Zhang J. Molecular structure, expression, and bioactivity of B-cell-activating factor of the TNF family (BAFF) and its receptor BAFF-R in cats (Felis catus). Mol Immunol 2019;112:59-71. [PMID: 31078117 DOI: 10.1016/j.molimm.2019.04.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Kaur K, Chowdhury S, Greenspan NS, Schreiber JR. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007;110:2948-54. [PMID: 17634409 DOI: 10.1182/blood-2007-01-069245] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
195 Viau M, Zouali M. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice. Mol Immunol 2005;42:849-55. [PMID: 15829273 DOI: 10.1016/j.molimm.2004.07.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
196 Corcoran LM. Transcriptional control of B cell activation. Curr Top Microbiol Immunol 2005;290:105-46. [PMID: 16480041 DOI: 10.1007/3-540-26363-2_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
197 Acosta-rodríguez EV, Merino MC, Montes CL, Motrán CC, Gruppi A. Cytokines and chemokines shaping the B-cell compartment. Cytokine & Growth Factor Reviews 2007;18:73-83. [DOI: 10.1016/j.cytogfr.2007.01.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
198 Nakajima K, Itoh K, Nagatani K, Okawa-Takatsuji M, Fujii T, Kuroki H, Katsuragawa Y, Aotsuka S, Mimori A. Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 2007;36:365-72. [PMID: 17963166 DOI: 10.1080/03009740701286615] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
199 Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M. Polymorphism in the 5′ regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjögren's syndrome. Rheumatology 2008;47:1311-6. [DOI: 10.1093/rheumatology/ken246] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
200 Stohl W. Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein: . Current Opinion in Rheumatology 2002;14:522-8. [DOI: 10.1097/00002281-200209000-00007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
201 Shah K, Cragg M, Leandro M, Reddy V. Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus. Biologicals 2021;69:1-14. [PMID: 33288390 DOI: 10.1016/j.biologicals.2020.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
202 Mariño E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 2014;44:983-93. [PMID: 24435807 DOI: 10.1002/eji.201344186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
203 Mooster JL, Le Bras S, Massaad MJ, Jabara H, Yoon J, Galand C, Heesters BA, Burton OT, Mattoo H, Manis J, Geha RS. Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα. J Exp Med 2015;212:185-202. [PMID: 25601653 DOI: 10.1084/jem.20140979] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
204 Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T, Tumas D, Grewal IS, Dixit VM. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2001;2:638-43. [PMID: 11429549 DOI: 10.1038/89790] [Cited by in Crossref: 311] [Cited by in F6Publishing: 281] [Article Influence: 15.6] [Reference Citation Analysis]
205 Su TT, Guo B, Wei B, Braun J, Rawlings DJ. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev 2004;197:161-78. [DOI: 10.1111/j.0105-2896.2004.0102.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
206 Shimizu T, Nakamura H, Kawakami A. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome. Int J Mol Sci 2021;22:3090. [PMID: 33803026 DOI: 10.3390/ijms22063090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Fletcher CA, Groom JR, Woehl B, Leung H, Mackay C, Mackay F. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice. J Autoimmun 2011;36:125-34. [PMID: 21216131 DOI: 10.1016/j.jaut.2010.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
208 Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest 2002;109:59-68. [DOI: 10.1172/jci0214121] [Cited by in Crossref: 554] [Article Influence: 29.2] [Reference Citation Analysis]
209 Li X, Ding Y, Zi M, Sun L, Zhang W, Chen S, Xu Y. CD19, from bench to bedside. Immunology Letters 2017;183:86-95. [DOI: 10.1016/j.imlet.2017.01.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
210 Moura RA, Canhão H, Polido-Pereira J, Rodrigues AM, Navalho M, Mourão AF, Resende C, Campanilho-Marques R, Madruga Dias J, da Silva JA, Graca L, Fonseca JE. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol 2013;40:1293-302. [PMID: 23772083 DOI: 10.3899/jrheum.121110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
211 Levit-Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity PC, Rajewsky K, Reth M, Hobeika E. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol 2016;196:2348-60. [PMID: 26843325 DOI: 10.4049/jimmunol.1501707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
212 Zhang P, Zhao Y, Sun XH. Notch-regulated periphery B cell differentiation involves suppression of E protein function. J Immunol 2013;191:726-36. [PMID: 23752615 DOI: 10.4049/jimmunol.1202134] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
213 Stohl W. Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development? Curr Rheumatol Rep 2012;14:303-9. [PMID: 22547203 DOI: 10.1007/s11926-012-0254-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
214 Stohl W, Looney RJ. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks? Clin Immunol 2006;121:1-12. [PMID: 16697258 DOI: 10.1016/j.clim.2006.03.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
215 Tandler C, Schmidt M, Heitmann JS, Hierold J, Schmidt J, Schneider P, Dörfel D, Walz J, Salih HR. Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia. Cancers (Basel) 2020;12:E2725. [PMID: 32977449 DOI: 10.3390/cancers12102725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Swee LK, Tardivel A, Schneider P, Rolink A. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF. Immunol Lett 2010;131:40-8. [PMID: 20350570 DOI: 10.1016/j.imlet.2010.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
217 Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 2006;118:281-92. [PMID: 16827889 DOI: 10.1111/j.1365-2567.2006.02377.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
218 Ju S, Wang Y, Ni H, Wang X, Jiang P, Kong X, Zhong R. Correlation of expression levels of BLyS and its receptors with multiple myeloma. Clinical Biochemistry 2009;42:387-99. [DOI: 10.1016/j.clinbiochem.2008.10.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
219 Khare SD, Hsu H. The role of TALL-1 and APRIL in immune regulation. Trends Immunol 2001;22:61-3. [PMID: 11286694 DOI: 10.1016/s1471-4906(00)01843-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
220 Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194:1691-1697. [PMID: 11733583 DOI: 10.1084/jem.194.11.1691] [Cited by in Crossref: 169] [Cited by in F6Publishing: 156] [Article Influence: 8.9] [Reference Citation Analysis]
221 Lugade AA, Bharali DJ, Pradhan V, Elkin G, Mousa SA, Thanavala Y. Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity. Nanomedicine: Nanotechnology, Biology and Medicine 2013;9:923-34. [DOI: 10.1016/j.nano.2013.03.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
222 Wong CK, Wong PTY, Tam LS, Li EK, Chen DP, Lam CWK. Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity. J Clin Immunol 2010;30:45-52. [DOI: 10.1007/s10875-009-9325-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 7.4] [Reference Citation Analysis]
223 Zouali M. B cell diversity and longevity in systemic autoimmunity. Molecular Immunology 2002;38:895-901. [DOI: 10.1016/s0161-5890(02)00016-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
224 Venkatesh J, Peeva E, Xu X, Diamond B. Cutting Edge: Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 2006;176:3311-4. [PMID: 16517697 DOI: 10.4049/jimmunol.176.6.3311] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
225 Baker KP. BLyS—an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmunity Reviews 2004;3:368-75. [DOI: 10.1016/j.autrev.2004.02.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
226 Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity?: New genetic defects in common variable immunodeficiency. Current Opinion in Allergy & Clinical Immunology 2005;5:496-503. [DOI: 10.1097/01.all.0000191887.89773.cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
227 Guerrettaz LM, Johnson SA, Cambier JC. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A 2008;105:11898-902. [PMID: 18697924 DOI: 10.1073/pnas.0805498105] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
228 Reda R, Abbas AA, Mohammed M, El Fedawy SF, Ghareeb H, El Kabarity RH, Abo-Shady RA, Zakaria D. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease. J Immunol Res. 2015;2015:846348. [PMID: 26504859 DOI: 10.1155/2015/846348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
229 Suekane S, Ueda K, Nishihara K, Sasada T, Yamashita T, Koga N, Yutani S, Shichijo S, Itoh K, Igawa T, Noguchi M. Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma. Cancer Sci 2017;108:2430-7. [PMID: 28940789 DOI: 10.1111/cas.13404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
230 Figgett WA, Fairfax K, Vincent FB, Le Page MA, Katik I, Deliyanti D, Quah PS, Verma P, Grumont R, Gerondakis S, Hertzog P, O'Reilly LA, Strasser A, Mackay F. The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death. Immunity 2013;39:573-83. [PMID: 24012421 DOI: 10.1016/j.immuni.2013.05.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
231 Kim SJ, Won JH. B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy. Leuk Lymphoma 2012;53:19-25. [PMID: 21740304 DOI: 10.3109/10428194.2011.603448] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
232 Nguyen TG, Morris JM. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo. Immunology Letters 2014;161:157-64. [DOI: 10.1016/j.imlet.2014.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
233 Itano AA, Sims MJ, Siu G. Mechanistic medicine: novel strategies for clinical trials. Autoimmunity 2010;43:560-71. [PMID: 20429849 DOI: 10.3109/08916931003674782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
234 Tanwar S, Dhar A, Varanasi V, Mukherjee T, Boppana R, Basak S, Bal V, George A, Rath S. Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinase. Sci Rep 2017;7:46029. [PMID: 28378771 DOI: 10.1038/srep46029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
235 Zhou B, Zhang H, Su X, Luo Y, Li X, Yu C, Xie Q, Xia X, He G, Yang L. Therapeutic effects of a novel BAFF blocker on arthritis. Signal Transduct Target Ther 2019;4:19. [PMID: 31231554 DOI: 10.1038/s41392-019-0051-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
236 Kim J, Gross JA, Dillon SR, Min J, Elkon KB. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 2011;44:69-81. [DOI: 10.3109/08916934.2010.509122] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
237 Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon-Mills A, Rickert RC, Karin M. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006;25:403-15. [PMID: 16973390 DOI: 10.1016/j.immuni.2006.07.010] [Cited by in Crossref: 129] [Cited by in F6Publishing: 125] [Article Influence: 8.6] [Reference Citation Analysis]
238 Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, Liesveld J, Sanz I, Baechler E, Kaplan MJ, Anolik JH. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol 2014;192:906-18. [PMID: 24379124 DOI: 10.4049/jimmunol.1302112] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
239 Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight 2019;5:129641. [PMID: 31408436 DOI: 10.1172/jci.insight.129641] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 24.0] [Reference Citation Analysis]
240 Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004;20:441-53. [PMID: 15084273 DOI: 10.1016/s1074-7613(04)00079-2] [Cited by in Crossref: 423] [Cited by in F6Publishing: 223] [Article Influence: 24.9] [Reference Citation Analysis]
241 Marks E, Ortiz C, Pantazi E, Bailey CS, Lord GM, Waldschmidt TJ, Noelle RJ, Elgueta R. Retinoic Acid Signaling in B Cells Is Required for the Generation of an Effective T-Independent Immune Response. Front Immunol 2016;7:643. [PMID: 28066447 DOI: 10.3389/fimmu.2016.00643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
242 Yiwen Z, Shilin G, Yingshi C, Lishi S, Baohong L, Chao L, Linghua L, Ting P, Hui Z. Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy. Oncotarget 2016;7:77732-48. [PMID: 27780916 DOI: 10.18632/oncotarget.12792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002;3:958-965. [PMID: 12352969 DOI: 10.1038/ni842] [Cited by in Crossref: 519] [Cited by in F6Publishing: 494] [Article Influence: 27.3] [Reference Citation Analysis]
244 Fink K, Zellweger R, Weber J, Manjarrez-Orduno N, Holdener M, Senn BM, Hengartner H, Zinkernagel RM, Macpherson AJ. Long-term maternal imprinting of the specific B cell repertoire by maternal antibodies. Eur J Immunol 2008;38:90-101. [PMID: 18081043 DOI: 10.1002/eji.200737872] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
245 Lim JY, Park MJ, Im KI, Kim N, Park HS, Lee SH, Kim EK, Nam YS, Lee ES, Cho ML, Cho SG. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease. Exp Hematol 2015;43:23-31.e1-2. [PMID: 25246268 DOI: 10.1016/j.exphem.2014.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
246 Jeganathan V, Peeva E, Diamond B. Hormonal milieu at time of B cell activation controls duration of autoantibody response. J Autoimmun 2014;53:46-54. [PMID: 24685232 DOI: 10.1016/j.jaut.2014.02.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
247 Petro JB, Gerstein RM, Lowe J, Carter RS, Shinners N, Khan WN. Transitional Type 1 and 2 B Lymphocyte Subsets Are Differentially Responsive to Antigen Receptor Signaling. Journal of Biological Chemistry 2002;277:48009-19. [DOI: 10.1074/jbc.m200305200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
248 Ware CF. APRIL and BAFF connect autoimmunity and cancer. J Exp Med. 2000;192:F35-F38. [PMID: 11104812 DOI: 10.1084/jem.192.11.f35] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
249 Gavin AL, Duong B, Skog P, Aït-azzouzene D, Greaves DR, Scott ML, Nemazee D. ΔBAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models. J Immunol 2005;175:319-28. [DOI: 10.4049/jimmunol.175.1.319] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 5.2] [Reference Citation Analysis]
250 Illes A, Varoczy L, Papp G, Wilson PC, Alex P, Jonsson R, Kovacs T, Konttinen YT, Zeher M, Nakken B, Szodoray P. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy. Scand J Immunol 2009;69:387-400. [PMID: 19508370 DOI: 10.1111/j.1365-3083.2009.02237.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
251 Caso F, Costa L, Nucera V, Barilaro G, Masala IF, Talotta R, Caso P, Scarpa R, Sarzi-Puttini P, Atzeni F. From autoinflammation to autoimmunity: old and recent findings. Clin Rheumatol. 2018;37:2305-2321. [PMID: 30014358 DOI: 10.1007/s10067-018-4209-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
252 Harless SM, Lentz VM, Sah AP, Hsu BL, Clise-dwyer K, Hilbert DM, Hayes CE, Cancro MP. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Current Biology 2001;11:1986-9. [DOI: 10.1016/s0960-9822(01)00598-x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
253 Puri KD, Gold MR. Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies. Front Immunol 2012;3:256. [PMID: 22936933 DOI: 10.3389/fimmu.2012.00256] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
254 McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL. BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol 2006;241:85-94. [PMID: 16987502 DOI: 10.1016/j.cellimm.2006.08.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
255 Stolp J, Mariño E, Batten M, Sierro F, Cox SL, Grey ST, Silveira PA. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice. J Immunol 2013;191:97-109. [PMID: 23740954 DOI: 10.4049/jimmunol.1203252] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
256 MacLennan I, Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 2002;17:235-238. [PMID: 12354377 DOI: 10.1016/s1074-7613(02)00398-9] [Cited by in Crossref: 127] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
257 Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013;59:169-177. [PMID: 23542089 DOI: 10.1016/j.jhep.2013.03.018] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 14.3] [Reference Citation Analysis]
258 Bachy E, Besson C, Suarez F, Hermine O. Hepatitis C virus infection and lymphoma. Mediterr J Hematol Infect Dis. 2010;2:e2010004. [PMID: 21415946 DOI: 10.4084/mjhid.2010.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
259 Diamanti AP, Rosado MM, Carsetti R, Valesini G. B cells in SLE: Different biological drugs for different pathogenic mechanisms. Autoimmunity Reviews 2007;7:143-8. [DOI: 10.1016/j.autrev.2007.02.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
260 Ueda-Hayakawa I, Tanimura H, Osawa M, Iwasaka H, Ohe S, Yamazaki F, Mizuno K, Okamoto H. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. Rheumatology (Oxford) 2013;52:1658-66. [PMID: 23685362 DOI: 10.1093/rheumatology/ket186] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
261 Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ. Discovery of high-affinity peptide binders to BLyS by phage display. J Mol Recognit 2005;18:94-102. [DOI: 10.1002/jmr.722] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
262 Huang Y, Fu X, Lyu X, Xu Z, He Z, Zhang Y, Zeng Y, He F, Huang G. Activation of LXR attenuates collagen-induced arthritis via suppressing BLyS production. Clin Immunol 2015;161:339-47. [PMID: 26431776 DOI: 10.1016/j.clim.2015.09.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
263 Rolink AG, Andersson J, Melchers F. Molecular mechanisms guiding late stages of B-cell development. Immunol Rev 2004;197:41-50. [DOI: 10.1111/j.0105-2896.2004.0101.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
264 Akkaya M, Pierce SK. From zero to sixty and back to zero again: the metabolic life of B cells. Curr Opin Immunol 2019;57:1-7. [PMID: 30312894 DOI: 10.1016/j.coi.2018.09.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
265 Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 2006;18:284-9. [PMID: 16931039 DOI: 10.1016/j.smim.2006.04.005] [Cited by in Crossref: 124] [Cited by in F6Publishing: 103] [Article Influence: 8.3] [Reference Citation Analysis]
266 Zhang M, Ko KH, Lam QL, Lo CK, Srivastava G, Zheng B, Lau YL, Lu L. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 2005;17:1081-92. [PMID: 16000326 DOI: 10.1093/intimm/dxh287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
267 Johnson AC, Davison LM, Giltiay NV, Vareechon C, Li X, Jørgensen TN. Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease. Eur J Immunol 2012;42:1695-705. [PMID: 22585710 DOI: 10.1002/eji.201142238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
268 Mustafa A, Holladay S, Witonsky S, Zimmerman K, Manari A, Countermarsh S, Karpuzoglu E, Gogal R. Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice. Birth Defects Res B Dev Reprod Toxicol 2011;92:82-94. [PMID: 21312323 DOI: 10.1002/bdrb.20285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
269 Buttmann M. Treating multiple sclerosis with monoclonal antibodies: a 2010 update. Expert Rev Neurother 2010;10:791-809. [PMID: 20420497 DOI: 10.1586/ern.10.38] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
270 Huard B, Schneider P, Mauri D, Tschopp J, French LE. T Cell Costimulation by the TNF Ligand BAFF. J Immunol 2001;167:6225-31. [DOI: 10.4049/jimmunol.167.11.6225] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 8.3] [Reference Citation Analysis]
271 Zhang X, Park C, Yoon S, Li L, Hsu Y, Ambrose C, Choi YS. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. International Immunology 2005;17:779-88. [DOI: 10.1093/intimm/dxh259] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 6.6] [Reference Citation Analysis]
272 Trescol-Biémont MC, Verschelde C, Cottalorda A, Bonnefoy-Bérard N. Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Biochimie 2004;86:287-94. [PMID: 15194232 DOI: 10.1016/j.biochi.2004.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
273 Gauld SB, Merrell KT, Cambier JC. Silencing of autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol 2006;18:292-7. [PMID: 16616480 DOI: 10.1016/j.coi.2006.03.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
274 Cildir G, Low KC, Tergaonkar V. Noncanonical NF-κB Signaling in Health and Disease. Trends Mol Med 2016;22:414-29. [PMID: 27068135 DOI: 10.1016/j.molmed.2016.03.002] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 26.8] [Reference Citation Analysis]
275 Zhu X, Shi Y, Sun J, Shan N, Peng J, Guo C, Qin P, Hou M. High-Dose Dexamethasone Inhibits BAFF Expression in Patients with Immune Thrombocytopenia. J Clin Immunol 2009;29:603-10. [DOI: 10.1007/s10875-009-9303-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
276 Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J, Kloczko J. The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Ann Hematol 2015;94:35-43. [PMID: 25085377 DOI: 10.1007/s00277-014-2178-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
277 Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 2005;204:43-54. [PMID: 15790349 DOI: 10.1111/j.0105-2896.2005.00219.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 5.7] [Reference Citation Analysis]
278 Do RK, Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev 2002;13:19-25. [PMID: 11750877 DOI: 10.1016/s1359-6101(01)00025-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
279 Zhou J, Tiemann K, Chomchan P, Alluin J, Swiderski P, Burnett J, Zhang X, Forman S, Chen R, Rossi J. Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Res 2013;41:4266-83. [PMID: 23470998 DOI: 10.1093/nar/gkt125] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
280 Fairfax K, Mackay IR, Mackay F. BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. IUBMB Life 2012;64:595-602. [PMID: 22641424 DOI: 10.1002/iub.1046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
281 Lee BH, Gauna AE, Pauley KM, Park YJ, Cha S. Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome. Clin Rev Allergy Immunol 2012;42:35-44. [PMID: 22105703 DOI: 10.1007/s12016-011-8288-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
282 Stohl W. Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders. Expert Opinion on Therapeutic Targets 2005;8:177-89. [DOI: 10.1517/14728222.8.3.177] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
283 Wang S, Yang T, Wan J, Zhang Y, Fan Y. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission. Brain Behav 2017;7:e00648. [PMID: 28413701 DOI: 10.1002/brb3.648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
284 Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW; BLISS-52 Study Group., BLISS-76 Study Group. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 2012;64:2328-37. [PMID: 22275291 DOI: 10.1002/art.34400] [Cited by in Crossref: 221] [Cited by in F6Publishing: 191] [Article Influence: 24.6] [Reference Citation Analysis]
285 Wildschütz L, Ackermann D, Witten A, Kasper M, Busch M, Glander S, Melkonyan H, Walscheid K, Tappeiner C, Thanos S, Barysenka A, Koch J, Heinz C, Laffer B, Bauer D, Stoll M, König S, Heiligenhaus A. Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis. J Autoimmun 2019;100:75-83. [PMID: 30885419 DOI: 10.1016/j.jaut.2019.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
286 Linher-Melville K, Shah A, Singh G. Sex differences in neuro(auto)immunity and chronic sciatic nerve pain. Biol Sex Differ 2020;11:62. [PMID: 33183347 DOI: 10.1186/s13293-020-00339-y] [Reference Citation Analysis]
287 Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators. J Immunol 2002;168:5993-6. [DOI: 10.4049/jimmunol.168.12.5993] [Cited by in Crossref: 235] [Cited by in F6Publishing: 218] [Article Influence: 12.4] [Reference Citation Analysis]
288 Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, Burns SO, Mauri C, Thrasher AJ. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol 2014;44:2692-702. [PMID: 24945741 DOI: 10.1002/eji.201344245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
289 Zhou X, Xia Z, Lan Q, Wang J, Su W, Han YP, Fan H, Liu Z, Stohl W, Zheng SG. BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One 2011;6:e23629. [PMID: 21897850 DOI: 10.1371/journal.pone.0023629] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
290 Oldham AL, Miner CA, Wang HC, Webb CF. The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Mol Immunol 2011;49:367-79. [PMID: 21963220 DOI: 10.1016/j.molimm.2011.09.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
291 Poudrier J, Chagnon-Choquet J, Roger M. Influence of dendritic cells on B-cell responses during HIV infection. Clin Dev Immunol 2012;2012:592187. [PMID: 22461837 DOI: 10.1155/2012/592187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
292 Andrews SF, Zhang Q, Lim S, Li L, Lee JH, Zheng NY, Huang M, Taylor WM, Farris AD, Ni D, Meng W, Luning Prak ET, Wilson PC. Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity. J Exp Med 2013;210:125-42. [PMID: 23267014 DOI: 10.1084/jem.20120525] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
293 Yeo SC, Liew A. Biologic agents in the treatment of glomerulonephritides. Nephrology (Carlton) 2015;20:767-87. [PMID: 26040770 DOI: 10.1111/nep.12530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
294 Clark JM, Aleksiyadis K, Martin A, McNamee K, Tharmalingam T, Williams RO, Mémet S, Cope AP. Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells. PLoS One 2011;6:e24504. [PMID: 21915344 DOI: 10.1371/journal.pone.0024504] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
295 Granato A, Hayashi EA, Baptista BJA, Bellio M, Nobrega A. IL-4 Regulates Bim Expression and Promotes B Cell Maturation in Synergy with BAFF Conferring Resistance to Cell Death at Negative Selection Checkpoints. J I 2014;192:5761-75. [DOI: 10.4049/jimmunol.1300749] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
296 Cieniewicz B, Santana AL, Minkah N, Krug LT. Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host. Front Microbiol 2016;7:1202. [PMID: 27582728 DOI: 10.3389/fmicb.2016.01202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
297 Xu LG, Shu HB. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 2002;169:6883-9. [PMID: 12471121 DOI: 10.4049/jimmunol.169.12.6883] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 6.3] [Reference Citation Analysis]
298 Veale MF, Dietrich WM, Corcoran LM. Knockout B lymphoma cell lines as biochemical tools to explore multiple signalling pathways. Immunol Cell Biol 2003;81:297-304. [PMID: 12848851 DOI: 10.1046/j.0818-9641.2003.01172.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
299 Yeramilli VA, Knight KL. Requirement for BAFF and APRIL during B cell development in GALT. J Immunol 2010;184:5527-36. [PMID: 20400696 DOI: 10.4049/jimmunol.1000146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
300 Lee K, Heffington L, Jellusova J, Nam KT, Raybuck A, Cho SH, Thomas JW, Rickert RC, Boothby M. Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 2013;122:2369-79. [PMID: 23958952 DOI: 10.1182/blood-2013-01-477505] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
301 Tolar P, Pierce SK. A conformation-induced oligomerization model for B cell receptor microclustering and signaling. Curr Top Microbiol Immunol 2010;340:155-69. [PMID: 19960313 DOI: 10.1007/978-3-642-03858-7_8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
302 Hoek KL, Carlesso G, Clark ES, Khan WN. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling. J Immunol 2009;183:5630-43. [PMID: 19843948 DOI: 10.4049/jimmunol.0901100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
303 Han Q, Yang C, Li N, Li F, Sang J, Lv Y, Zhao W, Li C, Liu Z. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection. Immunol Lett 2017;188:53-8. [PMID: 28627389 DOI: 10.1016/j.imlet.2017.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
304 Zhang F, Bae SC, Bass D, Chu M, Egginton S, Gordon D, Roth DA, Zheng J, Tanaka Y. A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 2018;77:355-63. [PMID: 29295825 DOI: 10.1136/annrheumdis-2017-211631] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 24.3] [Reference Citation Analysis]
305 Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol Rev 2010;237:90-103. [PMID: 20727031 DOI: 10.1111/j.1600-065X.2010.00942.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
306 Henriques A, Silva I, Inês L, Souto-carneiro MM, Pais ML, Trindade H, da Silva JAP, Paiva A. CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus. Clin Exp Med 2016;16:227-32. [DOI: 10.1007/s10238-015-0348-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
307 Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum 2007;56:1464-77. [PMID: 17469105 DOI: 10.1002/art.22603] [Cited by in Crossref: 145] [Cited by in F6Publishing: 131] [Article Influence: 10.4] [Reference Citation Analysis]
308 Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2014;18:473-89. [DOI: 10.1517/14728222.2014.888415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
309 Singh N, Chin I, Gabriel P, Blaum E, Masli S. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation. Int J Mol Sci 2018;19:E3117. [PMID: 30314337 DOI: 10.3390/ijms19103117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
310 von Bülow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity 2001;14:573-82. [PMID: 11371359 DOI: 10.1016/s1074-7613(01)00130-3] [Cited by in Crossref: 381] [Cited by in F6Publishing: 161] [Article Influence: 19.1] [Reference Citation Analysis]
311 Kalled SL, Ambrose C, Hsu Y. BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders. Expert Opinion on Therapeutic Targets 2005;7:115-23. [DOI: 10.1517/14728222.7.1.115] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
312 Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 2012;30:69-77. [PMID: 22231104 DOI: 10.1038/nbt.2076] [Cited by in Crossref: 91] [Cited by in F6Publishing: 258] [Article Influence: 10.1] [Reference Citation Analysis]
313 Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2:465-475. [PMID: 12094221 DOI: 10.1038/nri844] [Cited by in Crossref: 467] [Cited by in F6Publishing: 419] [Article Influence: 24.6] [Reference Citation Analysis]
314 Davidson A, Wang X, Mihara M, Ramanujam M, Huang W, Schiffer L, Sinha J. Co-Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE). Annals of the New York Academy of Sciences 2003;987:188-98. [DOI: 10.1111/j.1749-6632.2003.tb06048.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
315 Fletcher C, Sutherland A, Groom J, Batten M, Ng L, Gommerman J, Mackay F. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol 2006;36:2504-14. [DOI: 10.1002/eji.200636270] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
316 Atencio S, Amano H, Izui S, Kotzin BL. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 2004;172:4159-66. [PMID: 15034028 DOI: 10.4049/jimmunol.172.7.4159] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
317 Lu W, Cao P, Cai X, Yu J, Hu C, Cao M, Zhang S. Molecular cloning, expression, and bioactivity of dove B lymphocyte stimulator (doBAFF). Veterinary Immunology and Immunopathology 2009;128:374-80. [DOI: 10.1016/j.vetimm.2008.11.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
318 Lee J, Kuchen S, Fischer R, Chang S, Lipsky PE. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 2009;182:4116-26. [PMID: 19299709 DOI: 10.4049/jimmunol.0803391] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 8.0] [Reference Citation Analysis]
319 Li X, Su K, Ji C, Szalai AJ, Wu J, Zhang Y, Zhou T, Kimberly RP, Edberg JC. Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion. J Immunol 2008;181:1012-8. [PMID: 18606652 DOI: 10.4049/jimmunol.181.2.1012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
320 Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ 3rd, Brezski RJ, Treml LS, Jordan KA, Monroe JG, Sen R, Cancro MP. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol 2008;9:1379-87. [PMID: 18978795 DOI: 10.1038/ni.1666] [Cited by in Crossref: 156] [Cited by in F6Publishing: 146] [Article Influence: 12.0] [Reference Citation Analysis]
321 Secreto F, Manske M, Price-Troska T, Ziesmer S, Hodge LS, Ansell SM, Cerhan JR, Novak AJ. B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells. Leuk Lymphoma 2014;55:1884-92. [PMID: 24206092 DOI: 10.3109/10428194.2013.862619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
322 Jacob CO, Yu N, Guo S, Jacob N, Quinn WJ 3rd, Sindhava V, Cancro MP, Goilav B, Putterman C, Migone TS, Stohl W. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum 2013;65:1043-54. [PMID: 23334904 DOI: 10.1002/art.37846] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
323 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109:1587-1598. [PMID: 12070306 DOI: 10.1172/jci200215034] [Cited by in Crossref: 23] [Article Influence: 1.2] [Reference Citation Analysis]
324 Yu M, Chen Y, He Y, Podd A, Fu G, Wright JA, Kleiman E, Khan WN, Wen R, Wang D. Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells. J Immunol 2012;189:5185-93. [PMID: 23087406 DOI: 10.4049/jimmunol.1102952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
325 Aït-Azzouzene D, Gavin AL, Skog P, Duong B, Nemazee D. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen. Eur J Immunol 2006;36:985-96. [PMID: 16511898 DOI: 10.1002/eji.200535581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
326 Wang Q, Ma Y, Huang B, Liu D, Wei W. Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice. Molecular Immunology 2011;49:380-6. [DOI: 10.1016/j.molimm.2011.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
327 Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 2006;54:192-201. [PMID: 16385515 DOI: 10.1002/art.21526] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 12.1] [Reference Citation Analysis]
328 de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6:451-458. [PMID: 18387498 DOI: 10.1016/j.cgh.2008.02.011] [Cited by in Crossref: 237] [Cited by in F6Publishing: 202] [Article Influence: 18.2] [Reference Citation Analysis]
329 Yoshimoto K, Takahashi Y, Ogasawara M, Setoyama Y, Suzuki K, Tsuzaka K, Abe T, Takeuchi T. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy. International Immunology 2006;18:1189-96. [DOI: 10.1093/intimm/dxl053] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
330 Bermejo DA, Amezcua-Vesely MC, Montes CL, Merino MC, Gehrau RC, Cejas H, Acosta-Rodríguez EV, Gruppi A. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. PLoS Negl Trop Dis 2010;4:e679. [PMID: 20454564 DOI: 10.1371/journal.pntd.0000679] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
331 Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007;204:1959-71. [PMID: 17664289 DOI: 10.1084/jem.20062567] [Cited by in Crossref: 289] [Cited by in F6Publishing: 265] [Article Influence: 20.6] [Reference Citation Analysis]
332 Giltiay NV, Lu Y, Allman D, Jørgensen TN, Li X. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol 2010;185:99-109. [PMID: 20543113 DOI: 10.4049/jimmunol.0903312] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
333 Bojadzic D, Buchwald P. Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions. Curr Top Med Chem 2018;18:674-99. [PMID: 29848279 DOI: 10.2174/1568026618666180531092503] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
334 Routsias JG, Goules JD, Charalampakis G, Tzima S, Papageorgiou A, Voulgarelis M. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 2013;43:178-86. [PMID: 23816048 DOI: 10.1016/j.semarthrit.2013.04.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
335 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
336 Avery DT, Kalled SL, Ellyard JI, Ambrose C, Bixler SA, Thien M, Brink R, Mackay F, Hodgkin PD, Tangye SG. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 2003;112:286-97. [PMID: 12865416 DOI: 10.1172/JCI18025] [Cited by in Crossref: 281] [Cited by in F6Publishing: 147] [Article Influence: 15.6] [Reference Citation Analysis]
337 Mackay F, Groom JR, Tangye SG. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome. Current Opinion in Rheumatology 2007;19:406-13. [DOI: 10.1097/bor.0b013e328277ef4c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
338 Janda A, Rensing-Ehl A, Eibel H, Ehl S, Speckmann C. Elevated serum BAFF levels in patients with autoimmunity and lymphoproliferation. Scand J Immunol 2011;74:518-9. [PMID: 21790703 DOI: 10.1111/j.1365-3083.2011.02597.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
339 Aguirre-Valencia D, Ríos-Serna LJ, Posso-Osorio I, Naranjo-Escobar J, López D, Bedoya-Joaqui V, Nieto-Aristizábal I, Castro AM, Díaz-Ordoñez L, Navarro EP, Barrera MC, Echeverri A, Cañas CA, Tobón GJ. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers. J Transl Autoimmun 2020;3:100027. [PMID: 32743512 DOI: 10.1016/j.jtauto.2019.100027] [Reference Citation Analysis]
340 Bosello S, Pers J, Rochas C, Devauchelle V, De Santis M, Daridon C, Saraux A, Ferraccioli G, Youinou P. Baff and Rheumatic Autoimmune Disorders: Implications for Disease Management and Therapy. Int J Immunopathol Pharmacol 2007;20:1-8. [DOI: 10.1177/039463200702000101] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
341 Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 2001;2:276-9. [DOI: 10.1038/sj.gene.6363770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
342 Fuentes-Pananá EM, Bannish G, Shah N, Monroe JG. Basal Igalpha/Igbeta signals trigger the coordinated initiation of pre-B cell antigen receptor-dependent processes. J Immunol 2004;173:1000-11. [PMID: 15240688 DOI: 10.4049/jimmunol.173.2.1000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
343 Stohl W. SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. Arthritis Res Ther 2003;5:136-8. [PMID: 12723979 DOI: 10.1186/ar755] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
344 Grant JR, Moise AR, Jefferies WA. Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. Clin Vaccine Immunol 2007;14:907-17. [PMID: 17538121 DOI: 10.1128/CVI.00058-07] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
345 Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion. Eur J Immunol 2007;37:1785-95. [PMID: 17557373 DOI: 10.1002/eji.200636800] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
346 Fabris M, Grimaldi F, Villalta D, Picierno A, Fabro C, Bolzan M, De Vita S, Tonutti E. BLyS and April serum levels in patients with autoimmune thyroid diseases. Autoimmunity Reviews 2010;9:165-9. [DOI: 10.1016/j.autrev.2009.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
347 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109:1587-1598. [PMID: 12070306 DOI: 10.1172/jci0215034] [Cited by in Crossref: 168] [Article Influence: 8.8] [Reference Citation Analysis]
348 Monroe JG. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 2006;6:283-94. [PMID: 16557260 DOI: 10.1038/nri1808] [Cited by in Crossref: 209] [Cited by in F6Publishing: 202] [Article Influence: 13.9] [Reference Citation Analysis]
349 Guan Z, Yao W, Ye J, Dan W, Shen J, Zhang S. The construction and characterization of a bifunctional EGFP/sAPRIL fusion protein. Appl Microbiol Biotechnol 2007;73:1114-22. [PMID: 17021878 DOI: 10.1007/s00253-006-0591-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
350 Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ. Selective activation of TACI by syndecan-2. Blood 2006;107:3235-42. [PMID: 16357320 DOI: 10.1182/blood-2005-01-0256] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
351 Thangarajh M, Gomes A, Masterman T, Hillert J, Hjelmström P. Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis. J Neuroimmunol 2004;152:183-90. [PMID: 15223251 DOI: 10.1016/j.jneuroim.2004.03.017] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 3.9] [Reference Citation Analysis]
352 Kang S, Keener AB, Jones SZ, Benschop RJ, Caro-Maldonado A, Rathmell JC, Clarke SH, Matsushima GK, Whitmire JK, Vilen BJ. IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF. J Immunol 2016;196:196-206. [PMID: 26621863 DOI: 10.4049/jimmunol.1402527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
353 Lee-Chang C, Lefranc D, Salleron J, Faveeuw C, Allet C, Vermersch P, Oxombre B, Prin L. Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels. Immunol Lett. 2011;135:108-117. [PMID: 20946917 DOI: 10.1016/j.imlet.2010.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
354 Miosge LA, Goodnow CC. Genes, pathways and checkpoints in lymphocyte development and homeostasis. Immunol Cell Biol 2005;83:318-35. [DOI: 10.1111/j.1440-1711.2005.01353.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
355 Xu H, He X, Sun J, Shi D, Zhu Y, Zhang X. The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection. Transplantation Proceedings 2009;41:112-6. [DOI: 10.1016/j.transproceed.2008.10.037] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
356 Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004;173:2245-52. [PMID: 15294936 DOI: 10.4049/jimmunol.173.4.2245] [Cited by in Crossref: 270] [Cited by in F6Publishing: 258] [Article Influence: 15.9] [Reference Citation Analysis]
357 Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 2008;105:14993-8. [PMID: 18820032 DOI: 10.1073/pnas.0806044105] [Cited by in Crossref: 148] [Cited by in F6Publishing: 141] [Article Influence: 11.4] [Reference Citation Analysis]
358 Rauch M, Tussiwand R, Bosco N, Rolink AG. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 2009;4:e5456. [PMID: 19421318 DOI: 10.1371/journal.pone.0005456] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
359 Rodríguez-Alba JC, Moreno-García ME, Sandoval-Montes C, Rosales-Garcia VH, Santos-Argumedo L. CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen. Blood 2008;111:3644-52. [PMID: 18223169 DOI: 10.1182/blood-2007-08-107714] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
360 Parameswaran R, David HB, Sharabi A, Zinger H, Mozes E. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus. Clinical Immunology 2009;131:223-32. [DOI: 10.1016/j.clim.2008.12.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
361 Crowley JE, Stadanlick JE, Cambier JC, Cancro MP. FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood 2009;113:1464-73. [PMID: 18791164 DOI: 10.1182/blood-2008-02-138651] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
362 Scholz JL, Cancro MP. Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment. Immunol Lett 2012;143:2-8. [PMID: 22330846 DOI: 10.1016/j.imlet.2012.01.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
363 Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 2003;48:3475-86. [PMID: 14673998 DOI: 10.1002/art.11354] [Cited by in Crossref: 344] [Cited by in F6Publishing: 315] [Article Influence: 20.2] [Reference Citation Analysis]
364 Cabatingan MS, Schmidt MR, Sen R, Woodland RT. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol 2002;169:6795-805. [PMID: 12471111 DOI: 10.4049/jimmunol.169.12.6795] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
365 Vilas-Boas A, Morais SA, Isenberg DA. Belimumab in systemic lupus erythematosus. RMD Open 2015;1:e000011. [PMID: 26509047 DOI: 10.1136/rmdopen-2014-000011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
366 Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res 2011;21:223-44. [PMID: 21243012 DOI: 10.1038/cr.2011.13] [Cited by in Crossref: 460] [Cited by in F6Publishing: 424] [Article Influence: 46.0] [Reference Citation Analysis]
367 Guan Z, Ye J, Dan W, Yao W, Zhang S. Cloning, expression and bioactivity of duck BAFF. Molecular Immunology 2007;44:1471-6. [DOI: 10.1016/j.molimm.2006.05.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
368 Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011;1246:41-9. [PMID: 22236429 DOI: 10.1111/j.1749-6632.2011.06338.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
369 Teague BN, Pan Y, Mudd PA, Nakken B, Zhang Q, Szodoray P, Kim-Howard X, Wilson PC, Farris AD. Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J Immunol 2007;178:7511-5. [PMID: 17548583 DOI: 10.4049/jimmunol.178.12.7511] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
370 Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP, Jacquot S. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008;127:14-25. [PMID: 18191619 DOI: 10.1016/j.clim.2007.11.013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 7.1] [Reference Citation Analysis]
371 Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44. [PMID: 15843552 DOI: 10.4049/jimmunol.174.9.5537] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]
372 Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol 2003;24:343-9. [PMID: 12810111 DOI: 10.1016/s1471-4906(03)00119-4] [Cited by in Crossref: 144] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
373 La Cava A. Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol 2013;148:322-7. [PMID: 23269199 DOI: 10.1016/j.clim.2012.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
374 Kim SH, Kim YN, Jang YS. Cutting Edge: LL-37-Mediated Formyl Peptide Receptor-2 Signaling in Follicular Dendritic Cells Contributes to B Cell Activation in Peyer's Patch Germinal Centers. J Immunol 2017;198:629-33. [PMID: 27974458 DOI: 10.4049/jimmunol.1600886] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
375 Cohen S, Shachar I. Cytokines as regulators of proliferation and survival of healthy and malignant peripheral B cells. Cytokine 2012;60:13-22. [PMID: 22784632 DOI: 10.1016/j.cyto.2012.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
376 Haley SL, Tzvetkov EP, Meuwissen S, Plummer JR, McGettigan JP. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis. J Virol 2017;91:e02435-16. [PMID: 28148792 DOI: 10.1128/JVI.02435-16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
377 Kawabata D, Venkatesh J, Ramanujam M, Davidson A, Grimaldi CM, Diamond B. Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice. PLoS One 2010;5:e8418. [PMID: 20066044 DOI: 10.1371/journal.pone.0008418] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
378 Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol. 2009;10:778-785. [PMID: 19483719 DOI: 10.1038/ni.1741] [Cited by in Crossref: 332] [Cited by in F6Publishing: 316] [Article Influence: 27.7] [Reference Citation Analysis]
379 Shimomura Y, Ogawa A, Kawada M, Sugimoto K, Mizoguchi E, Shi HN, Pillai S, Bhan AK, Mizoguchi A. A unique B2 B cell subset in the intestine. J Exp Med 2008;205:1343-55. [PMID: 18519649 DOI: 10.1084/jem.20071572] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
380 Medina DJ, Goodell L, Glod J, Gélinas C, Rabson AB, Strair RK. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways. Haematologica 2012;97:1255-63. [PMID: 22371181 DOI: 10.3324/haematol.2011.040659] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
381 Cain D, Kondo M, Chen H, Kelsoe G. Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol 2009;129:266-77. [PMID: 19148216 DOI: 10.1038/jid.2008.286] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
382 Nair JJ, Singh TP. Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions. J Clin Exp Dent 2017;9:e584-9. [PMID: 28469828 DOI: 10.4317/jced.53605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
383 Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest. 2002;109:59-68. [PMID: 11781351 DOI: 10.1172/jci14121] [Cited by in Crossref: 15] [Cited by in F6Publishing: 232] [Article Influence: 0.8] [Reference Citation Analysis]
384 Xu H, He X, Liu Q, Shi D, Chen Y, Zhu Y, Zhang X. Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients. Transplant Proc 2009;41:1552-6. [PMID: 19545677 DOI: 10.1016/j.transproceed.2008.10.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
385 Tangye SG, Bryant VL, Cuss AK, Good KL. BAFF, APRIL and human B cell disorders. Semin Immunol 2006;18:305-17. [PMID: 16916610 DOI: 10.1016/j.smim.2006.04.004] [Cited by in Crossref: 149] [Cited by in F6Publishing: 128] [Article Influence: 9.9] [Reference Citation Analysis]
386 Bolkun L, Lemancewicz D, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, Dzieciol J. BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma. Ann Hematol 2014;93:635-44. [PMID: 24141333 DOI: 10.1007/s00277-013-1924-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
387 Bergamin F, Vincent IE, Summerfield A, McCullough KC. Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol 2007;37:3122-30. [PMID: 17935087 DOI: 10.1002/eji.200636791] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
388 Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Ther 2006;8:R6. [PMID: 16356193 DOI: 10.1186/ar1855] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
389 Wardemann H, Nussenzweig MC. B‐Cell Self‐Tolerance in Humans. Elsevier; 2007. pp. 83-110. [DOI: 10.1016/s0065-2776(07)95003-8] [Cited by in Crossref: 121] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
390 Verstappen GM, Pringle S, Bootsma H, Kroese FGM. Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis. Nat Rev Rheumatol 2021;17:333-48. [PMID: 33911236 DOI: 10.1038/s41584-021-00605-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
391 Dianzani U, Chiocchetti A, Ramenghi U. Role of inherited defects decreasing Fas function in autoimmunity. Life Sciences 2003;72:2803-24. [DOI: 10.1016/s0024-3205(03)00196-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
392 Zhang Z, Wang J, Zhang YH, Gardner TE, Fitzpatrick EA, Zhang W. Two Siblings Homozygous for F508del-CFTR Have Varied Disease Phenotypes and Protein Biomarkers. Int J Mol Sci 2021;22:2631. [PMID: 33807880 DOI: 10.3390/ijms22052631] [Reference Citation Analysis]
393 Hasler P, Zouali M. B cell receptor signaling and autoimmunity. FASEB J 2001;15:2085-98. [PMID: 11641235 DOI: 10.1096/fj.00-0860rev] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
394 Gardam S, Brink R. Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol 2014;4:509. [PMID: 24432023 DOI: 10.3389/fimmu.2013.00509] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
395 Cancro MP. Tipping the Scales of Selection with BAFF. Immunity 2004;20:655-6. [DOI: 10.1016/j.immuni.2004.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
396 Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Current Opinion in Immunology 2004;16:780-6. [DOI: 10.1016/j.coi.2004.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
397 Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945-50. [PMID: 19666484 DOI: 10.1073/pnas.0903543106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 20.8] [Reference Citation Analysis]
398 Lima J, Cambridge G, Vilas-Boas A, Martins C, Borrego LM, Leandro M. Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period. Am J Reprod Immunol 2019;81:e13090. [PMID: 30624814 DOI: 10.1111/aji.13090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
399 Liu H, Zhang J, Li J, Song J, Zhang S. Molecular structure, distribution, and immunology function of TNFSF13B (BAFF) in Nile tilapia (Oreochromis niloticus). Fish & Shellfish Immunology 2016;51:240-50. [DOI: 10.1016/j.fsi.2016.02.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
400 Wilhelmson AS, Lantero Rodriguez M, Stubelius A, Fogelstrand P, Johansson I, Buechler MB, Lianoglou S, Kapoor VN, Johansson ME, Fagman JB, Duhlin A, Tripathi P, Camponeschi A, Porse BT, Rolink AG, Nissbrandt H, Turley SJ, Carlsten H, Mårtensson IL, Karlsson MCI, Tivesten Å. Testosterone is an endogenous regulator of BAFF and splenic B cell number. Nat Commun 2018;9:2067. [PMID: 29802242 DOI: 10.1038/s41467-018-04408-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
401 Bossen C, Cachero TG, Tardivel A, Ingold K, Willen L, Dobles M, Scott ML, Maquelin A, Belnoue E, Siegrist CA, Chevrier S, Acha-Orbea H, Leung H, Mackay F, Tschopp J, Schneider P. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008;111:1004-12. [PMID: 17942754 DOI: 10.1182/blood-2007-09-110874] [Cited by in Crossref: 207] [Cited by in F6Publishing: 192] [Article Influence: 14.8] [Reference Citation Analysis]
402 Soh SY, Faveeuw C, Thiam CH, Khoo LHB, Yeo KP, Lim SY, Lim HY, Ng JX, Angeli V. NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E–Deficient Mice. J I 2016;197:3894-904. [DOI: 10.4049/jimmunol.1500999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
403 Newman R, Turner M. The Role of p110δ in the Development and Activation of B Lymphocytes. In: Schoenberger SP, Katsikis PD, Pulendran B, editors. Crossroads Between Innate and Adaptive Immunity V. Cham: Springer International Publishing; 2015. pp. 119-35. [DOI: 10.1007/978-3-319-15774-0_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
404 Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol. 2004;172:5086-5094. [PMID: 15067092 DOI: 10.4049/jimmunol.172.8.5086] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
405 Sugalski JM, Rodriguez B, Moir S, Anthony DD. Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection. J Immunol 2010;185:3019-27. [PMID: 20656924 DOI: 10.4049/jimmunol.1000879] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
406 Slupsky JR. Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types? Scientifica (Cairo) 2014;2014:208928. [PMID: 25101192 DOI: 10.1155/2014/208928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
407 Zhou L, Zhong R, Hao W, Wang H, Fan X, Zhang L, Mi Q. Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells. Exp Mol Pathol 2009;87:54-8. [PMID: 19393234 DOI: 10.1016/j.yexmp.2009.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
408 Cancro MP. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 2004;197:89-101. [DOI: 10.1111/j.0105-2896.2004.0099.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
409 Craxton A, Draves KE, Gruppi A, Clark EA. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005;202:1363-74. [PMID: 16301744 DOI: 10.1084/jem.20051283] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 9.6] [Reference Citation Analysis]
410 Cruickshank MN, Ulgiati D. The role of notch signaling in the development of a normal B‐cell repertoire. Immunol Cell Biol 2010;88:117-24. [DOI: 10.1038/icb.2009.73] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
411 Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004;173:807-817. [PMID: 15240667 DOI: 10.4049/jimmunol.173.2.807] [Cited by in Crossref: 339] [Cited by in F6Publishing: 323] [Article Influence: 19.9] [Reference Citation Analysis]
412 Grimaldi CM, Michael DJ, Diamond B. Cutting Edge: Expansion and Activation of A Population of Autoreactive Marginal Zone B Cells in a Model of Estrogen-Induced Lupus. J Immunol 2001;167:1886-90. [DOI: 10.4049/jimmunol.167.4.1886] [Cited by in Crossref: 220] [Cited by in F6Publishing: 183] [Article Influence: 11.0] [Reference Citation Analysis]
413 Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B, Metzger TE, Bixler SA, Hong YS, Ambrose CM, Mackay F, Morel L, Putterman C, Kotzin BL, Kalled SL. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum 2005;52:2080-91. [DOI: 10.1002/art.21138] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
414 De Groof A, Hémon P, Mignen O, Pers J, Wakeland EK, Renaudineau Y, Lauwerys BR. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus. Clinic Rev Allerg Immunol 2017;53:181-97. [DOI: 10.1007/s12016-017-8605-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
415 Hegazy M, Darwish H, Darweesh H, El-shehaby A, Emad Y. Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices. Clinical Immunology 2010;135:118-24. [DOI: 10.1016/j.clim.2009.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
416 Thompson SA, Jones JL, Cox AL, Compston DA, Coles AJ. B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. J Clin Immunol 2010;30:99-105. [PMID: 19763798 DOI: 10.1007/s10875-009-9327-3] [Cited by in Crossref: 156] [Cited by in F6Publishing: 144] [Article Influence: 13.0] [Reference Citation Analysis]
417 Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004;173:2331-41. [PMID: 15294946 DOI: 10.4049/jimmunol.173.4.2331] [Cited by in Crossref: 189] [Cited by in F6Publishing: 177] [Article Influence: 11.1] [Reference Citation Analysis]
418 Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002;2:945-56. [PMID: 12461567 DOI: 10.1038/nri955] [Cited by in Crossref: 432] [Cited by in F6Publishing: 394] [Article Influence: 24.0] [Reference Citation Analysis]
419 Vaux DL. The buzz about BAFF. J Clin Invest 2002;109:17-8. [DOI: 10.1172/jci0214780] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
420 Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Arthritis Rheum. 2004;50:1884-1896. [PMID: 15188365 DOI: 10.1002/art.20290] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
421 Daridon C, Burmester GR, Dörner T. Anticytokine therapy impacting on B cells in autoimmune diseases. Curr Opin Rheumatol 2009;21:205-10. [PMID: 19346949 DOI: 10.1097/BOR.0b013e32832a0760] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
422 Xiao B, Duan R, Link H, Huang Y. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells. Cellular Immunology 2003;223:63-9. [DOI: 10.1016/s0008-8749(03)00118-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
423 Youinou P. Is BAFF the murderer in lupus? Lupus 2008;17:613-4. [PMID: 18625632 DOI: 10.1177/0961203308092164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
424 Gorelik L, Cutler AH, Thill G, Miklasz SD, Shea DE, Ambrose C, Bixler SA, Su L, Scott ML, Kalled SL. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 2004;172:762-6. [PMID: 14707045 DOI: 10.4049/jimmunol.172.2.762] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 7.4] [Reference Citation Analysis]
425 Bizzaro N, Tozzoli R, Villalta D, Fabris M, Tonutti E. Cutting-Edge Issues in Celiac Disease and in Gluten Intolerance. Clinic Rev Allerg Immunol 2012;42:279-87. [DOI: 10.1007/s12016-010-8223-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
426 Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C, Cassatella MA. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 2003;197:297-302. [PMID: 12566413 DOI: 10.1084/jem.20021343] [Cited by in Crossref: 227] [Cited by in F6Publishing: 216] [Article Influence: 12.6] [Reference Citation Analysis]
427 Taher TE, Bystrom J, Ong VH, Isenberg DA, Renaudineau Y, Abraham DJ, Mageed RA. Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clin Rev Allergy Immunol 2017;53:237-64. [PMID: 28456914 DOI: 10.1007/s12016-017-8609-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
428 Kracker S, Gardes P, Mazerolles F, Durandy A. Immunoglobulin class switch recombination deficiencies. Clinical Immunology 2010;135:193-203. [DOI: 10.1016/j.clim.2010.01.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
429 Yeo SC, Liew A, Barratt J. Emerging therapies in immunoglobulin A nephropathy. Nephrology (Carlton) 2015;20:788-800. [PMID: 26032537 DOI: 10.1111/nep.12527] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
430 Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol 2005;25:551-72. [PMID: 16380819 DOI: 10.1007/s10875-005-8216-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
431 Kaminski DA, Stavnezer J. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J Immunol 2006;177:6025-9. [PMID: 17056527 DOI: 10.4049/jimmunol.177.9.6025] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
432 Sun J, Li Y, Sun Y, Yu M, Feng J, Shen B. Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator. Hybridoma 2006;25:80-5. [DOI: 10.1089/hyb.2006.25.80] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
433 Cunningham-Rundles C. Human B cell defects in perspective. Immunol Res 2012;54:227-32. [PMID: 22477523 DOI: 10.1007/s12026-012-8318-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
434 Liu M, Guo Q, Wu C, Sterlin D, Goswami S, Zhang Y, Li T, Bao C, Shen N, Fu Q, Zhang X. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol 2019;16:367-79. [PMID: 29563616 DOI: 10.1038/s41423-018-0010-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
435 Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002;17:525-35. [PMID: 12387745 DOI: 10.1016/s1074-7613(02)00423-5] [Cited by in Crossref: 675] [Cited by in F6Publishing: 311] [Article Influence: 35.5] [Reference Citation Analysis]
436 Rolink AG, Melchers F. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr Opin Immunol 2002;14:266-75. [PMID: 11869903 DOI: 10.1016/s0952-7915(02)00332-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
437 Guerrier T, Le Pottier L, Devauchelle V, Pers J, Jamin C, Youinou P. Role of toll-like receptors in primary Sjögren’s syndrome with a special emphasis on B-cell maturation within exocrine tissues. Journal of Autoimmunity 2012;39:69-76. [DOI: 10.1016/j.jaut.2012.01.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
438 Richez C, Truchetet ME, Schaeverbeke T, Bannwarth B. Atacicept as an investigated therapy for rheumatoid arthritis. Expert Opin Investig Drugs 2014;23:1285-94. [PMID: 25078871 DOI: 10.1517/13543784.2014.943835] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
439 Notley CA, Baker N, Ehrenstein MR. Secreted IgM Enhances B Cell Receptor Signaling and Promotes Splenic but Impairs Peritoneal B Cell Survival. J I 2010;184:3386-93. [DOI: 10.4049/jimmunol.0902640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
440 Karpusas M, Cachero TG, Qian F, Boriack-sjodin A, Mullen C, Strauch K, Hsu Y, Kalled SL. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. Journal of Molecular Biology 2002;315:1145-54. [DOI: 10.1006/jmbi.2001.5296] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 5.4] [Reference Citation Analysis]
441 Soldemo M, Karlsson Hedestam GB. Env-Specific Antibodies in Chronic Infection versus in Vaccination. Front Immunol 2017;8:1057. [PMID: 28928737 DOI: 10.3389/fimmu.2017.01057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
442 Schneider P, Tschopp J. BAFF and the regulation of B cell survival. Immunol Lett 2003;88:57-62. [PMID: 12853163 DOI: 10.1016/s0165-2478(03)00050-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
443 Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, Davidson A. Lowering anti-dsDNA antibodies--what's new? Lupus 2002;11:885-94. [PMID: 12529055 DOI: 10.1191/0961203302lu311rr] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
444 Beaudette-Zlatanova BC, Le PT, Knight KL, Zhang S, Zakrzewski S, Parthasarathy M, Stiff PJ. A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant 2013;48:85-93. [PMID: 22732699 DOI: 10.1038/bmt.2012.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
445 Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 2008;41:105-13. [PMID: 18061473 DOI: 10.1016/j.cyto.2007.09.015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
446 Sakai J, Akkoyunlu M. The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev 2017;30:991-1014. [PMID: 28855265 DOI: 10.1128/CMR.00046-17] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 8.8] [Reference Citation Analysis]
447 Bernardi AI, Andersson A, Grahnemo L, Nurkkala-Karlsson M, Ohlsson C, Carlsten H, Islander U. Effects of lasofoxifene and bazedoxifene on B cell development and function. Immun Inflamm Dis 2014;2:214-25. [PMID: 25866629 DOI: 10.1002/iid3.37] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
448 Sutherland AP, Mackay F, Mackay CR. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas. Pharmacology & Therapeutics 2006;112:774-86. [DOI: 10.1016/j.pharmthera.2006.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
449 Walters SN, Webster KE, Daley S, Grey ST. A Role for Intrathymic B Cells in the Generation of Natural Regulatory T Cells. J I 2014;193:170-6. [DOI: 10.4049/jimmunol.1302519] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
450 Gaudin E, Rosado M, Agenes F, Mclean A, Freitas AA. B-cell homeostasis, competition, resources, and positive selection by self-antigens. Immunol Rev 2004;197:102-15. [DOI: 10.1111/j.0105-2896.2004.0095.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
451 Stohl W. B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr Rheumatol Rep 2002;4:345-50. [PMID: 12126587 DOI: 10.1007/s11926-002-0044-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
452 Hahn M, Macht A, Waisman A, Hövelmeyer N. NF-κB-inducing kinase is essential for B-cell maintenance in mice. Eur J Immunol 2016;46:732-41. [PMID: 26593098 DOI: 10.1002/eji.201546081] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
453 Khan WN, Shinners NP, Castro I, Hoek KL. BAFF Receptor Regulation of Peripheral B-Lymphocyte Survival and Development. In: Cancro MP, editor. BLyS Ligands and Receptors. Totowa: Humana Press; 2010. pp. 19-41. [DOI: 10.1007/978-1-60327-013-7_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
454 Ni C, Oganesyan G, Welsh K, Zhu X, Reed JC, Satterthwait AC, Cheng G, Ely KR. Key Molecular Contacts Promote Recognition of the BAFF Receptor by TNF Receptor-Associated Factor 3: Implications for Intracellular Signaling Regulation. J Immunol 2004;173:7394-400. [DOI: 10.4049/jimmunol.173.12.7394] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
455 Mayne CG, Amanna IJ, Hayes CE. Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival. Mol Immunol 2009;47:590-9. [PMID: 19815275 DOI: 10.1016/j.molimm.2009.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
456 Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006;18:290-6. [PMID: 16931038 DOI: 10.1016/j.smim.2006.06.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
457 Hikida M, Johmura S, Hashimoto A, Takezaki M, Kurosaki T. Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development. J Exp Med 2003;198:581-9. [PMID: 12913095 DOI: 10.1084/jem.20030280] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
458 Martins C, Lima J, Cambridge G, Ângelo-Dias M, Leandro M, Miguel Borrego L. Serum markers of B-cell activation in pregnant women with atopic asthma. Am J Reprod Immunol 2021;86:e13414. [PMID: 33682259 DOI: 10.1111/aji.13414] [Reference Citation Analysis]
459 Moreaux J, Sprynski AC, Dillon SR, Mahtouk K, Jourdan M, Ythier A, Moine P, Robert N, Jourdan E, Rossi JF, Klein B. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur J Haematol 2009;83:119-29. [PMID: 19456850 DOI: 10.1111/j.1600-0609.2009.01262.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
460 Hansen A, Hiepe F, Dörner T. Developments in lupus 2006. Arthritis Res Ther 2007;9:215. [PMID: 17634152 DOI: 10.1186/ar2183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
461 Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest 2015;125:2194-202. [PMID: 25938780 DOI: 10.1172/JCI78084] [Cited by in Crossref: 136] [Cited by in F6Publishing: 77] [Article Influence: 22.7] [Reference Citation Analysis]
462 Stohl W. A therapeutic role for BLyS antagonists. Lupus 2004;13:317-22. [DOI: 10.1191/0961203304lu1019oa] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
463 Smith SH, Cancro MP. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 2003;170:5820-3. [PMID: 12794106 DOI: 10.4049/jimmunol.170.12.5820] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 6.0] [Reference Citation Analysis]
464 Zhang Z, Zhou L, Yang X, Wang Y, Zhang P, Hou L, Hu X, Xing Y, Liu Y, Li W, Han H. Notch-RBP-J-independent marginal zone B cell development in IgH transgenic mice with VH derived from a natural polyreactive antibody. PLoS One 2012;7:e38894. [PMID: 22719978 DOI: 10.1371/journal.pone.0038894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
465 Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu Y, Whitty A. Selectivity of BAFF/BLyS and APRIL for Binding to the TNF Family Receptors BAFFR/BR3 and BCMA. Biochemistry 2005;44:1919-31. [DOI: 10.1021/bi048227k] [Cited by in Crossref: 115] [Cited by in F6Publishing: 102] [Article Influence: 7.2] [Reference Citation Analysis]
466 Seo Y, Mun CH, Park SH, Jeon D, Kim SJ, Yoon T, Ko E, Jo S, Park YB, Namkung W, Lee SW. Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2. Int J Mol Sci 2020;21:E4975. [PMID: 32674502 DOI: 10.3390/ijms21144975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
467 Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends in Immunology 2002;23:113-5. [DOI: 10.1016/s1471-4906(01)02159-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
468 Amano H, Amano E, Moll T, Marinkovic D, Ibnou-zekri N, Martinez-soría E, Semac I, Wirth T, Nitschke L, Izui S. The Yaa Mutation Promoting Murine Lupus Causes Defective Development of Marginal Zone B Cells. J Immunol 2003;170:2293-301. [DOI: 10.4049/jimmunol.170.5.2293] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
469 Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006;107:4540-8. [PMID: 16497967 DOI: 10.1182/blood-2005-10-4042] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 8.3] [Reference Citation Analysis]
470 Tusche MW, Ward LA, Vu F, McCarthy D, Quintela-Fandino M, Ruland J, Gommerman JL, Mak TW. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med 2009;206:2671-83. [PMID: 19917778 DOI: 10.1084/jem.20091802] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
471 Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol 2014;10:365-73. [PMID: 24614588 DOI: 10.1038/nrrheum.2014.33] [Cited by in Crossref: 227] [Cited by in F6Publishing: 198] [Article Influence: 32.4] [Reference Citation Analysis]
472 Lin W, Seshasayee D, Lee WP, Caplazi P, McVay S, Suto E, Nguyen A, Lin Z, Sun Y, DeForge L, Balazs M, Martin F, Zarrin AA. Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus. Arthritis Rheumatol 2015;67:215-24. [PMID: 25303150 DOI: 10.1002/art.38907] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
473 Samitas K, Lötvall J, Bossios A. B Cells: From Early Development to Regulating Allergic Diseases. Arch Immunol Ther Exp 2010;58:209-25. [DOI: 10.1007/s00005-010-0073-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
474 Dufait I, Liechtenstein T, Lanna A, Bricogne C, Laranga R, Padella A, Breckpot K, Escors D. Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica (Cairo) 2012;2012:694137. [PMID: 23526794 DOI: 10.6064/2012/694137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
475 Samardzic T, Marinkovic D, Nielsen PJ, Nitschke L, Wirth T. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol 2002;22:8320-31. [PMID: 12417733 DOI: 10.1128/MCB.22.23.8320-8331.2002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
476 Park YW, Pryshchep S, Seyler TM, Goronzy JJ, Weyand CM. B cells as a therapeutic target in autoimmune diseases. Expert Opinion on Therapeutic Targets 2005;9:431-45. [DOI: 10.1517/14728222.9.3.431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
477 Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002;2:323-35. [PMID: 12033738 DOI: 10.1038/nri799] [Cited by in Crossref: 602] [Cited by in F6Publishing: 540] [Article Influence: 31.7] [Reference Citation Analysis]
478 Suryani S, Fulcher DA, Santner-Nanan B, Nanan R, Wong M, Shaw PJ, Gibson J, Williams A, Tangye SG. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 2010;115:519-29. [PMID: 19965666 DOI: 10.1182/blood-2009-07-234799] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
479 Veiga-fernandes H, Freitas AA. The S(c)ensory Immune System Theory. Trends in Immunology 2017;38:777-88. [DOI: 10.1016/j.it.2017.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
480 Nakamura A, Nukiwa T, Takai T. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcγRIIB-deficient mice. Journal of Autoimmunity 2003;20:227-36. [DOI: 10.1016/s0896-8411(03)00034-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
481 Khan WN, Wright JA, Kleiman E, Boucher JC, Castro I, Clark ES. B-lymphocyte tolerance and effector function in immunity and autoimmunity. Immunol Res 2013;57:335-53. [DOI: 10.1007/s12026-013-8466-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
482 Hatada EN, Do RKG, Orlofsky A, Liou H, Prystowsky M, Maclennan ICM, Caamano J, Chen-kiang S. NF-κB1 p50 Is Required for BLyS Attenuation of Apoptosis but Dispensable for Processing of NF-κB2 p100 to p52 in Quiescent Mature B Cells. J Immunol 2014;171:761-8. [DOI: 10.4049/jimmunol.171.2.761] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 6.3] [Reference Citation Analysis]
483 Abdelwahab FA, Hassanein KM, Hetta HF, Abdelmalek MO, Zahran AM, El-Badawy O. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus. Sci Rep 2020;10:20383. [PMID: 33230233 DOI: 10.1038/s41598-020-77416-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]